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Abstract 
 
Sensitivity, Non-Equilibrium Thermodynamic and Control Analyses of Insulin 
Metabolic Signaling Pathways 
 
Ensheng Liu 
Advisor: Dr. Jian-Min Yuan 
 
 
 
The transportation of glucose, the primary energy source of all eukaryotic cells, from 
the bloodstream to the cells is catalyzed by a family of glucose transporters (GLUTs), 
among which GLUT4 is insulin stimulated and regulated.  To study the insulin-
stimulated glucose transport, we analyze the hybrid metabolic and signaling pathway 
models constructed by Sedaghat, et al. by applying multiple strategies based on dyna-
mic sensitivity analysis, concentration control analysis, non-equilibrium thermodyna-
mics, and nonlinear dynamics.  In dynamic sensitivity analysis, we have calculated the 
time-dependent sensitivities of the concentration of the membrane GLUT4 with respect 
to all the reaction parameters (reaction rate constants and initial concentrations of the 
effectors).  The roles of feedbacks are investigated by using dynamic sensitivities.  In 
addition, the integrated sensitivities of the membrane GLUT4 have been used to rank 
the accumulated influence of each reaction parameter on the membrane GLUT4.   
Results are consistent with experimental facts and predictions of drug targets in the 
literature.  Furthermore, a strategy is developed using dynamic concentration and sensi-
tivity analyses to control certain outputs of the insulin pathways.  The objective is to 
enhance the accumulated action of the membrane GLUT4 for a fixed amount of insulin 
input.  
  xiv
In the application of non-equilibrium thermodynamics, we calculate the fluxes, 
chemical affinities, and energy dissipated rates associated with each of the reaction 
steps of the pathways.  The flux and chemical affinity associated with the GLUT4 
translocation to the plasma membrane show clear sign of backflow, after the insulin 
application is suddenly switched off.  This backflow results in the decrease in the 
concentration of membrane GLUT4, thus the reduction of glucose transport.  
Stimulated by these results, we have carried out a study of insulin dosage delivery 
aimed at enhancing the duration of the high concentration period of membrane GLUT4, 
that is, increasing insulin efficiency using various insulin input functions.  Negative 
feedback and/or delay often cause oscillatory behaviors of a network system.  This 
phenomenon reveals itself in the present insulin model as well.  Nonlinear dynamical 
analysis and power spectra have been applied to the study of the complex oscillations 
associated with effectors concentrations. 
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Chapter 1:  Introduction to the research background 
The thesis presents a theoretical investigation on the mathematical models of metabolic 
insulin signaling pathways, which are related to the metabolic dynamic analyses and 
pharmaceutical drug targets of Type 2 diabetes mellitus.  By applying multiple quanti-
tative analyses on the available mathematical models of the insulin regulation network, 
we unravel some dynamic and regulation properties of the reaction kinetics related to 
insulin pathways. 
1.1 What is diabetes mellitus 
Diabetes mellitus is the metabolic failure of body cells to uptake glucose, commonly 
known as blood sugar, into tissue cells.  The unused blood glucose results in hyper-
glycemia (high blood sugar).  This may cause many complications such as ketoacidosis, 
nonketotic hyperosmolar coma, cardiovascular attack, chronic renal failure, retinal 
damage, nerve damage, to name a few.   
The earliest record for the recognition of the diabetes-like polyuric symptom 
was on an antique Egypt papyrus dating back to 3000 years ago [1].  The name of the 
disease ‘diabetes’ was given by an ancient Greek physician, Aretaeus of Cappadocia 
[2], in about the second century AD.  The meaning of ‘diabetes’ is ‘passing through’ or 
‘siphon’ [3], describing the excessive urine output of disease patients.  In about the 
fifth century AD, two Indian physicians Susruta and Charuka, identified the sweet taste 
in the urine of the diabetes patients.  Similar descriptions about the sweet urine 
symptom are also found in records of Chinese and Japanese physicians at about the 
same time.  The Latin word mellitus, meaning ‘honey’, was appended to the name of 
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the disease by an English physician, Thomas Willis (1621-1675).  He also realized that 
increased drinking of unallayed wine resulted in more opportunities of the disease in 
his time.  About a century later, the first experimental identification of the elevated 
sugar level in blood of diabetes patients was published by another English physician, 
Matthew Dobson (1735-1784).  Willis and Dobson are generally considered as the 
pioneers of the diagnose period of diabetes mellitus [1].  
In the late nineteenth century, the pathogenesis experiments on diabetes were 
started. In about 1889, a physician, Joseph Von Mering (1849-1908), and a scientist, 
Oskar Minkowski (1858-1931), at the University of Strassburg in Germany discovered 
that dogs with the pancreas removed progressed symptoms of diabetes. They deduced 
that the blood sugar is regulated by a chemical substance produced in the pancreas.  In 
1910, the English physiologist Sir Edward Albert Sharpey-Schafer (1850-1935) first 
used the word ‘insulin’ to name the chemical substance produced in the islets of 
Langerhans in the pancreas. In 1921-1922, the surgeon Sir Frederick Banting (1891-
1941) and the professor John Macleod (1876-1935) and coworkers at the University of 
Toronto in Canada isolated insulin from bovine pancreases and made insulin injection 
as the treatment method for diabetes mellitus. Because of their pioneering work in 
insulin, they were awarded the Nobel Prize for Physiology or Medicine in 1923.  The 
first distinction of Type 1 and Type 2 diabetes was made by the English scientist Sir 
Harold Percival Himsworth (1905-1993) in 1936.  
Now it is well known that insulin is the peptide hormone that regulates the 
uptake of glucose (blood sugar) by tissue cells.  Diabetes mellitus is caused by the 
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inability of β-cells in the pancreas to secrete insulin, and/or the inefficiency for the 
proper function of insulin. The function of insulin is to regulate the uptake of glucose 
(blood sugar) into the tissue cells.  
Glucose is the one of the primary energy sources and metabolic intermediates 
for eukaryotic cells. Glucose is initially produced in photosynthesis process in plants 
and some prokaryotes.  Sources of glucose in humans are the digestion of carbohy-
drates in food, the glycogenolysis from glycogen stored in liver, and the gluconegenesis 
from non-carbohydrate intermediates in liver and kidneys.  Glucose enters metabolic 
cycling in the form of blood sugar.  The transport of glucose from blood into tissue 
cells is facilitated by a group of glucose transporters (GLUT1-GLUT12), which are 
structurally related proteins with tissue-specific expressions [ 4 ].  Among all the 
glucose transporters, GLUT4 is the widely distributed in insulin-sensitive adipose 
tissue cells and striated (skeletal and cardiac) muscles [5].  Normally, when the blood 
glucose level elevates (for example, after meals), insulin is released from the pancreas 
to normalize it. The normal range of blood glucose concentration should be maintained 
within narrow limits throughout the day: 4 to 8 mMol/l, lower in the morning and 
higher after the meals. Dysfunctional glucose uptake into muscle and adipose tissues 
may result in circulating plasma glucose levels outside the reasonable range of 
physiological condition. This dysfunctional condition may cause several metabolic 
diseases – low glucose concentration may cause seizures, loss of consciousness, and 
even death; high glucose concentration may cause Type 2 diabetes mellitus, together 
with related syndromes such as blindness, renal failure, cardiac and peripheral vascular 
disease, and neuropathy [6].  
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In our research, we mainly focus on the insulin regulated membrane GLUT4 
concentration, which is mostly related to Type 2 diabetes mellitus.  More information 
about the types of diabetes and the patient distribution in these types are clarified in the 
next section.  
1.2 Types of diabetes mellitus 
According to the World Health Organization [7], there are three officially recognized 
types of diabetes mellitus.  They are called Type 1, Type 2 and Gestational diabetes, 
respectively. 
Type 1 diabetes was previously diagnosed in children or young people. It is 
caused by the failure of β-cells in pancreas to secrete enough or any insulin.  The β-
cells are attacked by the autoimmune system of the body which is generally related to 
genetic defects.  Patients of Type 1 diabetes have absolute shortage of insulin and must 
rely on the insulin treatment for relieving the symptom. Type 1 diabetes is also known 
as juvenile-onset diabetes mellitus (JODM) or insulin dependent diabetes (IDDM). 
Type 2 diabetes was previously diagnosed in adult or aged people. It is caused 
by the inhibited ability of body cells to utilize insulin to regulate the uptake of glucose.  
As a response, the pancreas excretes excessive insulin to increase the insulin uptake. 
The inhibition to utilize insulin is called insulin resistance, which is a typical 
characteristic of Type 2 diabetes.  Type 2 diabetes is also known as adult-onset diabetes 
mellitus (AODM) or non-insulin dependent diabetes mellitus (NIDDM).  
The difference of age distribution of Type 1 and Type 2 diabetes is now less 
distinct tham before.  Cases of Type 1 diabetes in adults and Type 2 diabetes in young-
sters are being diagnosed. 
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Gestational diabetes is a temporary symptom of diabetes that is diagnosed 
during woman’s pregnancy.  It is caused by the change of hormone levels due to 
pregnancy.  The symptom is most likely resolved after the birth of the baby.  But it also 
has a 25% to 50% probability of developing into Type 2 diabetes.  
There are some non-standardized types of diabetes. An example is when the 
symptom of Type 1 diabetes, the β-cell failure, in adults develops into the symptom of 
Type 2 diabetes, the insulin resistance.  This is sometimes called Type 1.5 diabetes or 
latent autoimmune diabetes of adults (LADA).  Another example is when the symptom 
of Alzheimer’s or Type 1 diabetes in the brain progresses into Type 2 diabetes. This 
was recently been called Type 3 diabetes or "double diabetes". 
There has been a steady increase in the diabetes population in the world.  In 
2000, about 150 million adults worldwide were diagnosed with diabetes mellitus. The 
expected population of diabetes is 300 million in the year of 2025.  The percentage 
increase of the diabetes in this period is 30 percent in developing countries, 125 percent 
in developed countries. Among all the diabetes patients, 90 percent suffer from Type 2 
diabetes, 10 percent from Type 1 diabetes.  
1.3 Diabetes treatment 
Except for women patients with gestational diabetes who can recover from the 
symptom and return to normal health condition, all patients with other types of diabetes 
will never have the automatic recovery.  Therefore, treatment is a necessity for survival 
of patients with diabetes mellitus. Diabetes treatment aims to improve the uptake of 
glucose and reduce the concentration of the blood sugar.  Different treatment strategies 
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such as physical exercise, diabetic diet, and insulin therapy are applied to patients with 
different types of diabetes mellitus. 
Good health is helpful for improving the sensitivity of cells to insulin.  So 
physical exercise is necessary for the patients to improve their health.  A well-designed 
diet with balanced nutrition of low sugar, fat, and cholesterol will also regulate the 
glucose levels. Insulin therapy is usually the direct injection of insulin into the 
circulation system of the body to help remove glucose from blood.  But more 
convenient insulin preparations such as insulin cartridge, insulin pump, inhalation, 
intranasal, transdermal, pill, etc. are available for different symptom requirements [8].   
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Chapter 2:  Research motivation and the landmarks of the thesis 
The rapid rise in the incidence of diabetes has made it one of the top threats to human 
health and the medical burden of diabetes has cost hundreds of billion of dollars world-
wide [9].  As a consequence much research has been made in the study of insulin/ 
glucose regulation strategies and efficient treatment methodology.    
Of all the glucose transport modeling efforts, the insulin regulated GLUT4 is 
among the most studied models [6, 10 , 11 , 12 ].  Experimental results to date (e.g. 
[13,14,15,16]) have provided the framework of in the insulin regulated GLUT4 sig-
naling pathways.  The initial triggering of the signals is the attachment of insulin to the 
outer side of cell membrane.  The signal is transferred inside to stimulate a series of 
downward reactions in this order:  
• Insulin attaches itself to the outer part of the insulin receptor the combi-
nation of the insulin with the insulin receptors docking in the membrane.  
• The insulin-bound insulin receptors stimulate the phosphorylation of the 
insulin receptors. 
• The phosphorylated insulin receptors trigger the phosphorylations of the 
insulin receptor substrates and activation of phosphoinositide-3 kinase 
(PI3K). 
• PI3K activates phosphatidylinositol (4,5)-bisphosphate (PIP2) to become 
phosphatidylinositol (3,4,5)-trisphosphate (PIP3). 
• PIP3 catalyzes the activation of the subsequent protein kinases 
(PKB/Akt and PKC-ζ). 
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• The activated protein kinases promote the exocytosis of GLUT4 
translocation from cytoplasm to its membrane form. 
To complement the experimental studies, mathematical modeling of signaling 
path-ways based on up-to-date experimental data have increasingly been accepted as 
reliable means to study the dynamic behaviors of the pathways. The mathematical 
models for the insulin-stimulated and regulated GLUT4 reaction network have been 
constructed by Quon and co-workers [17,18,19]. The models yield results reasonably 
consistent with the limited experimental data.  
Mathematical models can be used to make predictions and to evaluate our 
understanding of biological system.  Focusing on the hybrid (metabolic and signaling) 
mathematical models of Quon and coworkers [17], we have applied multiple analytical 
tools, including time-dependent sensitivity, control strategy, non-equilibrium 
thermodynamics, and nonlinear dynamics, to the studies of the metabolic insulin 
signaling pathways.  
Apart from Chapter 1, which provides the introduction to the research 
background materials on diabetes, and this chapter, which states briefly the motivation 
of the research and the organization of the whole thesis, the following chapters give the 
details of the models and results of our research as well as possible future develop-
ments.  
Chapter 3 introduces the models of the metabolic insulin pathways, constructed 
by Sedaghat and co-workers [17].  According to their functions, we group the effectors 
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and their reactions into 5 modules.  Each module has an input catalyst to trigger the 
reactions inside and an output to the downstream module or final product. There are 
also two feedback loops, one positive and one negative, existing in the reaction 
network. These loops bring about the complexity of the network and result in some 
interesting features.  
In Chapter 4, we present an effector dynamic sensitivity analysis of the models.  
Sensitivity expresses the response of an effector to the perturbation of a system 
parameter in the network, which, in turn, can be used for the control and regulation of 
the network.  Starting from the chemical kinetic equations, we derive the kinetic equa-
tions of the sensitivities through a differentiation.  These equations are used for the 
calculations of sensitivities discussed in Chapter 5, and for the study of dynamic 
control in Chapter 6.    
In Chapter 5, we use dynamic sensitivities to understand the effects of various 
feed-back conditions.  Due to the complexities of the reaction network, the sensitivity 
curves show the complex temporal behaviors.  To rank the drug targets associated with 
the insulin pathways, we use two ways: one based on integrated sensitivities, another 
based on the peak values of the dimensionless sensitivity curves.  The rankings provide 
information on vulnerable points associated with the reaction network.   
In Chapter 6, we apply the Newton-Raphson control strategy to find the values 
of system parameters that achieve certain output goals.  Two control methods are 
discussed we set: One is the time-point concentration control, in which we set the 
output concentration at some pre-defined time point as our target; another is the time-
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integrated concentration control, in which the target is the integrated concentration in a 
predefined time period.  
Chapter 7 contains the non-equilibrium thermodynamic analysis of the reaction 
network.  Results are presented on the dynamic properties of fluxes, chemical affinities, 
and the entropy production rates (EPRs) of the network.  In particular, we present the 
feedback effect on the flux, affinity, and EPR of exodytosis of GLUT4, as well as the 
effects of the removal of insulin.  
In Chapter 8, we analyze the dynamic properties of the reaction network.  The 
result reveals the nonlinear behaviors of the reaction network.  By adjusting the 
parameters of negative feedback, we switch on and off of the oscillatory behavior of 
effector concentrations.   
Chapter 9 presents the effects of insulin delivery curves.  This study was 
motivated by the parameter control analysis in which we show that a continuous insulin 
delivery is much better than a step-function delivery in generating long duration of a 
high concentration of membrane GLUT4.  The functional forms of delivery curves that 
we have tried are Gaussian, exponential, and Rayleigh-like.  By adjusting the shape we 
obtained different improvement of the cumulative concentration of membrane GLUT4. 
The backflows of the GLUT4 exocytosis are significantly reduced. 
Chapter 10 summarizes our findings followed by discussion of possible future 
directions of the whole research in Chapter 11.  In the last chapter we point out the 
  10
several drawbacks of the phenomenological models and some directions for future 
developments. 
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Chapter 3:  The insulin pathway models 
3.1  Modular representation of the models 
The dynamic models of the metabolic insulin signaling pathways that we analyze are 
those of Sedaghat and coworkers [17], who constructed two mathematical models: a 
model with feedbacks and a model without feedbacks. For clarity, these pathways are 
partitioned into five modules: the insulin receptor (IR) module, the insulin receptor 
substrate (IRS) module, the phosphatidylinositol phosphate (PIP) module, the PKC and 
Akt (PKC/Akt) module, and the GLUT4 module. The modularized reaction schemes 
with the chemical species are schematically presented in Figure 1.  Figures 2-6 present 
the reaction schemes in each module.  The reaction equations, the detailed descriptive 
names of the reaction species, the ordinary differential equations of the chemical 
kinetics, the values and expressions of the reaction rates, and the initial concentration 
values are listed in Tables 1-6.  
There exist both a positive feedback and a negative feedback in the model with 
feedbacks.  In the pathways, the phosphorylated insulin receptors and IRS-1 are de-
phosphorylated by PTP1B. In the model with feedbacks, the positive feedback comes 
from the phosphorylation of PTP1B itself by the activated Akt, resulting in reduced 
capability of PTP1B to dephosphorylate the insulin receptors and IRS-1. So the posi-
tive feedback loops from the PKC/Akt module to the IR and IRS modules. In the 
absence of the positive feed-back, the parameter [PTP] takes the value 1.00 under the 
normal physiological conditions.  With the positive feedback, the activated Akt reduces 
the PTP1B activity level by 25% at the maximum activated Akt concentration of 11%, 
therefore, [PTP] is given by  
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where Vmax is the maximal velocity, Kd is the dissociation constant, τ is the time lag, 
and n is the Hill coefficient. Detailed biochemical reaction information of the network 
can be found in Figure 1 and reference [17]. 
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This present biochemical network is an open system, in which there are three 
inputs: the insulin (x1), the unbound intracellular insulin receptor (x6), and the intra-
cellular GLUT4 (x20). The last two inputs are fluxes of x6 and x20 corresponding to 
synthesis at constant rates, which are accompanied by degradations. These synthesis 
and degradations have the potential of making the reaction system a non-static one.  
⎥⎦
⎤⎢⎣
⎡ −=
100
11
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1100.1][ 17xPTP
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in the feedback model of Sedaghat, et al. [17]. 
The negative feedback results from the action of the PKC/Akt module onto the 
IRS module, in which phosphorylated PKC-ζ activates the serine-phosphorylation of 
IRS-1, which impairs the complex formation of phosphorylated IRS-1 and activated 
PI3K and effectively results in reduced IRS-1 concentration available for tyrosine 
phosphorylation and the subsequent PI3K activation.  In the Sedaghat model, the PKC-
ζ feedback signal is represented by a multiplicative factor, [PKC], in the form of a 
standard Hill equation 
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Figure １:  Modular representation of the metabolic insulin signaling network. Detailed information about the reaction 
kinetics can be found in [1].
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Figure ２:  Schematic of reactions in the insulin receptor (IR) module. 
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Figure ３:  Schematic of reactions in IRS module. 
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Figure ４:  Schematic of reactions in PIP module. 
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Figure ５:  Schematic of reactions in PKC/Akt module. 
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Figure ６:  Schematic of reactions in GLUT4 module. 
 
Table 1:  The reaction schemes of the metabolic insulin signaling network (When there 
is no negative feedback, reaction (19) is ignored). 
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Table 2:  Reaction species of the metabolic insulin signaling network. 
  x1 = Molar concentration of insulin in blood 
  x2 = Molar concentration of unbound surface insulin receptors 
  x3 = Molar concentration of unphosphorylated once-bound surface receptors 
  x4 = Molar concentration of phosphorylated twice-bound surface receptors 
  x5 = Molar concentration of phosphorylated once-bound surface receptors 
  x6 = Molar concentration of unbound unphosphorylated intracellular receptors  
  x7 = Molar concentration of phosphorylated twice-bound intracellular receptors 
  x8 = Molar concentration of phosphorylated once-bound intracellular receptors 
  x9 = Molar concentration of unphosphorylated IRS-1 
 x10 = Molar concentration of tyrosine-phosphorylated IRS-1 
 x11 = Molar concentration of unactivated PI 3-Kinase 
 x12 = Molar concentration of tyrosine-phosphorylated IRS-1/activated PI 3-kinase 
complex 
 x13 = Percentage concentration of PI(3,4,5)P3 out of the total lipid population 
 x14 = Percentage concentration of PI(4,5)P2 out of the total lipid population 
 x15 = Percentage concentration of PI(3,4)P2 out of the total lipid population 
 x16 = Percentage concentration of unactivated Akt 
 x17 = Percentage concentration of activated Akt 
 x18 = Percentage concentration of unactivated PKC-ζ 
 x19 = Percentage concentration of activated PKC-ζ 
 x20 = Percentage concentration of intracellular GLUT4 
 x21 = Percentage concentration of cell surface GLUT4 
x10a = Molar concentration of serine-phosphorylated IRS-1 
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Table 3:  Dynamic concentration reaction equations of the metabolic insulin reaction 
network with feedbacks. When there are no feedbacks, the equation for x10a is ignored, 
k7’ and k-7’ are both zero, the expression for concentration of PTP is also different. 
Details of values of parameters are listed in Table 4. 
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Table 4:  Values of reaction parameters of the metabolic insulin signaling network. 
k1 6 × 107 M-1⋅min-1 
k-1 0.20 min-1 
k2 6 × 107 M-1⋅min-1 
k-2 200.0 min-1 
k3 2500.00 min-1 
k-3 0.20 min-1 
k4 0.000333 min-1 
k-4 0.003 min-1 
k4’  2.1 × 10-3 min-1 
k-4’ 2.1 × 10-4 min-1 
k5 (x6 + x6 + x6) > 1 × 10-13 ? 1.67 × 10-17 : 1 × 10-16 M⋅min-1 
k-5 1.66667 × 10-18 min-1 
k6 0.461 min-1 
k7 4.16 min-1 
k-7 1.396 min-1 
k7’ negfeed ? 0.346574 : 0 min-1 
k-7’ negfeed ? 0.085576 : 0 min-1 
k8 7.06464 × 1011 M-1⋅min-1 
k-8 10.0 min-1 
k9 negfeed ? (4.94066 × 1014x12 + 0.131449) : (2.52 × 1014x12 + 0.131449) 
min-1 
k-9 42.1483871 min-1 
k10 2.961 min-1 
k-10 2.77 min-1 
k11 0.248387•(x13 + 0.31) min-1 
k-11 6.93 min-1 
k12 0.248387•(x13 + 0.31) min-1 
k-12 6.93 min-1 
k13 0.006958333 min-1 
k-13 0.167 min-1 
k13’ 0.104375•effect min-1 
k14 0.11088 M⋅min-1 
k-14 0.001155 min-1 
 
k9stim 1.39 min-1 
k9basal  0.131449 min-1 
 
IRp 8.97 × 10-13 M
PI3K negfeed ? 2.54733 × 10-15: 5.0 × 10-15 M
PKC Vmax•x19n(t - τ)/(x19n(t - τ) + kdn) 
PTEN 1.0
PTP posfeed ? 1.0•max(0.11•(1.0 – 0.25x17), 0) : 1.0
SHIP 1.0
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APequil 9.091 
effect min(0.11(0.2x17 + 0.8x18), 1)
 
Vmax 20
Kd 12
N 4
τ 1.5 min
 
Instep 1.0  × 10-7 M
Stepdur 15.0 min
 
Table 5:  Initial concentrations of the reaction species. 
x2[0] 9.0 × 10-13 M
x3[0] 0 M
x4[0] 0 M
x5[0] 0 M
x6[0] 1.0 × 10-13 M
x7[0] 0 M
x8[0] 0 M
x9[0] 1.0 × 10-12 M
x10[0] 0 M
x11[0] 1.0 × 10-13 M
x12[0] 0 %
x13[0] 0.31 % 
x14[0] 99.4 %
x15[0] 0.29 %
x16[0] 100 %
x17[0] 0 %
x18[0] 100 %
x19[0] 0 %
x20[0] 96 %
x21[0] 4 %
x10a[0] 0 M
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The present models of metabolic insulin signaling pathways of Sedaghat, et al. 
[17] are among the most studied models in the literature [20,21,22,23,24]. However, 
many details of enzyme kinetics and effector interactions at the molecular level are still 
missing, thus the models are more phenomenological in nature than, for example, the 
models for cancers [25,26,27,28].  Focusing on the model of Sedaghat, et al. [17], we 
intend to illustrate that the theoretical and computational methods introduced here are 
generally useful in providing information for a biochemical network, here a network 
related to Type 2 diabetes mellitus.  
3.2 Dynamic concentrations resulting from the models 
Dynamic concentration curves are the direct result of mathematical models. The 
consistency of the concentrations predicted by the mathematical models and those from 
the experiments is the most important evaluation criterion of the effectiveness of the 
mathematical network. In the paper of Sedaghat et al. [17], dynamic concentration 
curves from both the model without feedbacks and with feedbacks were produced.  
Both models produce consistent insulin dose-response curves of the reaction species in 
the step insulin input concentration ranging from 10-12 M to 10-6 M.  The response 
concentrations of the species are taken at 15 minute, which is the full stimulation time 
of insulin to the GLUT4 translocation. Especially, the models with feedbacks produced 
transient oscillation behaviors in the dynamic concentration of the activated PKC-ζ.  
To start our research, we constructed our own C++ code package by using the 
fourth-order Runge-Kutta method to integrate the dynamic concentration and sensi-
tivity ordinary differential equations.  As the starting step, we regenerated the dyna-
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mical concentration curves identical to those in the paper of Sedaghat, et al. [17]. 
Moreover, we investigated the concentrations of the species under the four feedback 
conditions – no feedbacks, positive feedback alone, negative feedback alone, and both 
feedbacks.  The insulin delivery is a step function with initial concentration 10-7 M and 
re-moved at 15 minute.  Figure 7 shows the dynamic concentration of activated PKC-ζ 
under the four feedback concentrations.  The insulin stimulates the increasing of the 
concentration in about 1.5 minute.  After the removal of insulin at 15 minute, the 
concentration recovers back to the initial condition in a longer time (30 minutes).  From 
the diagram we can see that positive feedback increases the concentration curve of the 
activated PKC-ζ above the one without feedbacks. Negative feedback triggers the 
transient oscillation of the concentration, this oscillation still happens when both 
feedbacks are switched on.  Except for the initial oscillation peak, the curves of the 
negative feedback and overall feedback effects of both feedbacks are both lower than 
the curve without feedback in the effective time – 50 minutes of insulin regulation.   
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Figure ７:  Concentration of activated PKC-ζ under the four feedback conditions.  The 
solid line is concentration curve under the both-feedback model which shows 
consistency with the experimental data in the paper of Sedaghat, et al. [17].  
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Chapter 4:  Time-dependent sensitivity analysis 
Sensitivity analysis has been widely used in dynamical systems of various fields 
[29,30,31,32].  It can be used to facilitate the analysis of complicated systems, for 
example, in calculating system responses to certain parameter changes, in selecting 
important variables and parameters of the system for the purpose of system reduction, 
etc.  As in a previous paper [33], our emphasis here is on the application of time-
dependent sensitivities to non-steady-state systems, such as, biological pathways.  
4.1 Theoretical fundamentals of sensitivity analysis 
The set of ordinary differential equation for the metabolic insulin signaling pathways 
can be written as, 
),,( tf
dt
dx
i
i px= , i = 1, 2, … n,                                             (4.1) 
where xi (i = 1, 2, …, n) is the ith component of x, the concentration vector of n 
chemical species, fi is the reaction rate formula for xi. p is the m-vector of system 
parameters which include reaction rate constants, phosphatase concentrations, and 
feedback control parameters. The model of metabolic insulin signaling pathways 
without feedbacks or with positive feedback alone consists of 20 chemical components 
and 45 system parameters.  The system parameters consist of 28 rate constants, 3 
phosphatase concentrations, 2 input fluxes, and 12 non-zero initial concentrations.  
When negative feedback is switched on, it stimulates the serine-phosphorylation of 
IRS-1 with the feedback signal formularized by the Hill equation in (3.2).  Therefore, 
in the models with negative feedback alone or both positive and negative feedbacks, 
there are 21 chemical components and 52 system parameters.  The system parameters 
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consist of the same 45 system parameters plus 2 reversible reaction rate constants of the 
serine-phosphorylation of IRS-1 and the 5 negative feedback parameters. 
The set of differential equations satisfied by the time-dependent sensitivities 
[31,32, 33,34] can be obtained by differentiating directly Equations (4.1) with respect 
to the parameter pj, 
( )
j
i
n
k
kjikij p
fStJS
dt
d
∂
∂+= ∑
=1
,                                              (4.2) 
where 
j
i
ij p
xS ∂
∂=  is the sensitivity coefficient of concentration xi with respect to system 
parameter pj, ( )
k
i
ik x
f
tJ ∂
∂=  is a Jacobian matrix element. Equations (4.2) are a set of 
first-order first-degree differential equations, each with an inhomogeneous source term, 
if fi contains pj explicitly. Since concentrations appear in the sensitivity differential 
equations, the set of sensitivity Equations (4.2) should be solved in tandem with 
Equations (4.1). Thus for each pj, there are 2n ordinary differential equations to be 
solved. The initial condition of 
j
i
p
x
∂
∂
 is 0 if pj is a reaction parameter, δij if pj is the 
initial condition for species xi, i.e., δij = 1 if pj = xi(0). In our sensitivity and control 
studies, the coupled differential equations are solved numerically using the fourth-order 
Runge-Kutta method [35]. Of course, a positive Sij implies an increasing response of xi 
to an increase in pj, and vice versa for a negative Sij. In the models the concentrations of 
some reaction species (effectors in the PIP, PKC/Akt, and GLUT4 modules) are 
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conveniently expressed as percentages. This will not affect comparisons among the 
sensitivities, as long as we use the normalized sensitivities 
j
i
p
x
ln
ln
∂
∂
.    
In total, there are over a thousand sensitivity coefficients, for example, 21 × 52 
= 1092 coefficients for the model with negative or both feedbacks. However, as to 
diabetes the most important coefficients seem to be those related to the plasma 
membrane GLUT4 (x21). Therefore, in this section, we will focus on the sensitivities of 
x21, the concentration of plasma membrane GLUT4, with respect to all the parameters, 
including all the reaction rate constants, phosphatase concentrations, feedback para-
meters, and initial conditions. 
4.2 Profiles of dynamic sensitivity curves 
In the model without feedbacks, if we define ‘forward’ as going downstream, 
the values of x21 sensitivities with respect to the forward reaction rates are usually 
positive, and with respect to backward rates are negative.  This is the reason that the 
flux of the forward reaction tends to increase the concentrations of the subsequent 
species and the final output, but flux of the backward reactions has the opposite effect. 
Feedback loops take the concentration information from the downstream species and 
feed it to the upper stream to make regulations – the positive feedback tends to increase 
the concentration of membrane GLUT4, while the negative feedback decreases it.  The 
switching-on of the feedback loops generally changes the amplitudes of the fluxes in 
the affected loop but not the directions.  So the feedbacks do not change the signs of the 
sensitivities, although the looping structure disturbs the upward and downward order of 
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the reactions.  Figure 8 shows the sensitivities  
2
21
k
x
∂
∂  and 
7
21
−∂
∂
k
x .  The increase of k2 
increases the forward flux k2x3, resulting in higher concentrations of sub-sequent 
phosphorylated once- and twice-bound membrane insulin receptors (x4 + x5), which 
further promotes output of the reaction network – the GLUT4 translocation. So the sign 
of 
2
21
k
x
∂
∂  is negative under all the feedback conditions.  The increase of k-7 increases the 
backward flux k-7[PTP]x10, resulting in a lower concentration of subsequent phosphor-
rylated insulin receptor substrate IRS-1 (x10), which further inhibits the GLUT4 trans-
location.  So the sign of 
7
21
−∂
∂
k
x  is negative under all the feedback conditions.  The sensi-
tivities of membrane GLUT4 with respect to the non-zero initial concentrations of the 
kinases and receptors are all positive, because they eventually enhance the amount of 
membrane GLUT4.  Figure 9 shows the sensitivities ( )06
21
k
x
∂
∂  and ( )020
21
k
x
∂
∂ , both of them 
are positive under all the feedback conditions. 
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Figure ８: Examples of dynamic sensitivities of membrane GLUT4 to reaction rate 
cons-tants 
2
21
k
x
∂
∂  (A) and 
7
21
−∂
∂
k
x  (B) under all the feedback conditions. The former is 
always po-sitive and the latter is always negative. 
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Figure ９:  Examples of dynamic sensitivities of membrane GLUT4 to non-zero initial 
concentrations of chemical species ( )06
21
x
x
∂
∂  in (A) and ( )020
21
k
x
∂
∂  in (B) under all the 
feedback conditions. They are always positive. 
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4.3 Complexities introduced by feedbacks 
Sensitivity curves often provide us with insightful dynamic information about system 
behaviors not available by considering concentration curves alone. For example, the 
concentration curves of PKC-ζ and Akt are identical under any conditions – when they 
are unactivated or activated, with or without feedbacks. Figures 10A and 10B show the 
concentration curves of the unactivated PKC-ζ (x16) and Akt (x18). But the sensitivities 
of membrane GLUT4 with respect to their respective initial unactivated concentrations 
are far from similar due to the feedback effects (see Figures 10C and 10D). In the 
activated forms they carry different weights (Akt 20% and PKC-ζ 80%) in stimulating 
the exocytosis rate of GLUT4.  Furthermore, they play different roles in feedbacks (Akt 
is involved in the positive feedback loop and PKC-ζ is in the negative feedback loop).  
From their sensitivity curves we can see the different effects of feedbacks on their 
curve shapes.  When there are no feedbacks, their sensitivity curves are similar but in 
different scales. Positive-feedback-alone and both-feedback reduce the membrane 
GLUT4 sensitivity with respect to PKC-ζ in a large scale (Figure 10D), but enhance 
the membrane GLUT4 sensitivity to Akt (Figure 10C).  Negative-feedback-alone 
curves are also dissimilar.  The overall effect is that Akt and PKC-ζ have very different 
sensitivities.  As a result, under the both-feedback condition, the integrated sensitivity 
to Akt is larger than that of PKC-ζ, which is counter-intuitive since PKC-ζ has a larger 
share in the intracellular GLUT4 to membrane GLUT4 reaction.  
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Figure １０ :  Feedback effects on concentrations and on sensitivity curves of 
unactivated PKC-ζ and Akt. (A) Concentration curve of PKC-ζ and (B) Concentration 
curve of Akt.  The two curves show strong similarity. (C) Sensitivity curve of 
membrane GLUT4 with respect to PKC-ζ and (D) Sensitivity curve of membrane 
GLUT4 with respect to Akt.  These two curves behave very differently.  Solid curves 
denote the results of the model with both the positive and negative feedbacks; dashed 
curves denote the results of the model without feedbacks; dotted curves denote the 
results of the model with only the positive feedback; and dash-dotted curves denote the 
results of the model with only the negative feedback.   
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We can examine Figures 10C and 10D from another aspect, which reveals the 
interplay of positive and negative feedbacks in the dynamics of sensitivities.  In Figure 
10C, which presents the sensitivity of membrane GLUT4 with respect to the initial 
concentration of Akt, we see the similarity between the no-feedback and negative-
feedback curves for a large range of time.  Both are low and structureless.  However, 
there is a large peak at this later stage in the positive-feedback curve due certainly to 
the positive feedback effect of Akt.  The both-feedback curve, representing the 
combined feedback effects, thus lies somewhere in between.  In Figure 10D, presenting 
the sensitivity of membrane GLUT4 with respect to the initial concentration of PKC-ζ, 
we see the similarity between the no-feedback and positive-feedback curves for the 
later stage of time.  Negative feedback greatly depresses the sensitivity curve compared 
to the no-feedback case, as revealed by the negative-feedback and both-feedback 
curves.  The latter two are similar to each other.  It is interesting to see that, contrary to 
Figure 10C, the both-feedback curve lies outside the negative- and positive-feedback 
curves at a later time.  Thus in this range, positive feedback contributes to the reduction 
of sensitivity.   
Figure 10 is just an example to illustrate that the feedbacks existing in the 
insulin network have significant effects on the shapes of sensitivity curves, especially, 
the inhibition effects of the negative feedback.  The time-delayed negative feedback 
hinders the forward reactions in the network, results in reduced sensitivity values, and, 
in some parameter range, causes oscillatory behaviors of concentrations and sensi-
tivities.  
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4.4 Grouping of sensitivities according to shape similarities of sensitivity curves 
Shape similarities are observed in the time evolutions of sensitivities.  Thus, sensi-
tivities can be collected into groups according to the shapes of their dynamic curves. In 
each group, the sensitivities have similar or even identical temporal behaviors.  Sen-
sitivities having similar shapes, but opposite signs are also included in the same group.  
Most of similarities can be explained by the closeness in functions of the corresponding 
parameters towards the membrane GLUT4.  Often these parameters are associated with 
the same module.  However, there are exceptions, where parameters belong to different 
modules yield similar temporal behaviors in the sensitivities of membrane GLUT4. The 
former cases will be called Type I behavior and the latter cases Type II. 
We give some examples of Type I and Type II behaviors below. 
1) Type I examples, where similar shape of sensitivity curves comes from 
parameters in the same module. In the IRS module, the phosphorylation of the IRS-1 
(x9) is catalyzed by the once- and twice-bound membrane insulin receptors (x4 + x5). 
Subsequently, the phosphorylated IRS-1 (x10) associates with unactivated PI3K (x11) to 
form a protein complex (x12), which phosphorylates PI(4,5)P2 (x14) to become 
PI(3,4,5)P3 (x13) in the subsequent PIP module. PI(3,4,5)P3 leads to the activation of 
protein kinases B (x16) and C (x18), a key kinase for the GLUT4 translocation. 
Therefore, larger initial concentrations of x9 and x11 will enhance the final con-
centration of plasma membrane GLUT4. As shown in Figure 11, the following sensi-
tivities, 
8
21
ln
ln
k
x
∂
∂  (positive), 
8
21
ln
ln
−∂
∂
k
x  (negative),
)0(ln
ln
9
21
x
x
∂
∂  (positive), and 
)0(ln
ln
11
21
x
x
∂
∂  
(positive), in the IRS module have similar shape, where x9(0) and x11(0) are the initial 
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concentrations of insulin substrate IRS-1 and phosphatidylinositol 3-kinase (PI3K), 
respectively; k8 and k-8 are the forward and backward reaction rates for the complex 
formation reaction between phosphorylated IRS-1 binds and PI3K. As shown in Figure 
11, the similarity exists for all four feedback cases (no-feedback, positive feedback, 
negative feedback and both-feedback). In later figures (Figures 12 and 13) we present 
data for all four cases as well. 
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Figure １１:  Grouping of sensitivity curves in the IRS module according to shape 
similarity.  Solid curves denote the results of the model with both the positive and 
negative feedbacks; dashed curves denote the results of the model without feedbacks; 
dotted curves denote the results of the model with only the positive feedback; and dash-
dotted curves denote the results of the model with only the negative feedback.  (A) 
8
21
ln
ln
k
x
∂
∂ ; (B) 
8
21
ln
ln
−∂
∂
k
x ; (C) ( )0ln
ln
9
21
x
x
∂
∂ ; (D) ( )0ln
ln
11
21
x
x
∂
∂ . 
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Another Type I example is the following group of sensitivities: 
9
21
ln
ln
−∂
∂
k
x  
(negative), 
)0(ln
ln
14
21
x
x
∂
∂  (positive), and 
]ln[
ln 21
PTEN
x
∂
∂
 (negative) in the PIP module 
(Figure 12).  k-9 is the dephosphorylation rate of PI(3,4,5)P3 back to PI(3,4)P2 (x14), but 
a larger initial concentration of PI(3,4)P2, x14(0), causes the increase of PI(3,4,5)P3, 
therefore, k-9 and x14(0) have opposite sensitivity signs, but similar curve shape. Similar 
parallelism exists between the two sensitivity pairs, 
11
21
ln
ln
−∂
∂
k
x  and 
)0(ln
ln
16
21
x
x
∂
∂ , and 
12
21
ln
ln
−∂
∂
k
x  and 
)0(ln
ln
18
21
x
x
∂
∂  (not shown here). The parameter [PTEN], expressing the 
action of the phosphatase PTEN, is a constant multiplier to the dephosphorylation rate 
constant k-9, thus, it has identical dimensionless sensitivity curves under any feedback 
conditions. Similar parallelism exists between the sensitivity pair, 
10
21
ln
ln
−∂
∂
k
x  and 
]ln[
ln 21
SHIP
x
∂
∂
.  
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Figure １２:  Grouping of sensitivity curves in the PIP module according to shape 
similarity.  Solid curves denote the results of the model with both the positive and 
negative feedbacks; dashed curves denote the results of the model without feedbacks; 
dotted curves denote the results of the model with only the positive feedback; and dash-
dotted curves denote the results of the model with only the negative feedback.  (A) 
9
21
ln
ln
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∂
k
x ; (B) ( )0ln
ln
14
21
x
x
∂
∂ ; (C) 
]ln[
ln 21
PTEN
x
∂
∂
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2) Type II example where similar shapes of sensitivity curves are observed for 
parameters that are not associated with the same module. An example is the sensitivity 
pair, ( )0ln
ln
2
21
x
x
∂
∂  and 
7
21
ln
ln
k
x
∂
∂ , which have almost identical curve shapes as shown in 
Figure 13.  x2(0) is the initial concentration of the unbound surface insulin receptors 
and k7 is the phosphorylation rate constant of the insulin receptor substrate IRS-1 (x9), 
so the two sensitivities belong to different modules. Under the assumption of insulin 
concentration, higher initial concentration of the unbound surface insulin receptors x2(0) 
results in higher concentration of phosphorylated once- and twice-bound insulin 
receptors (x4 + x5).  They are the kinases promoting the tyrosine-phosphorylation of the 
IRS-1 and thus play the same role as the rate constant k7. Phosphorylated IRS-1, of 
course, promotes the formation of the complex (x12) of the phosphrylated IRS-1 and 
PI3K, thus causes the concentration of the plasma membrane GLUT4 (x21) to increase, 
thus both sensitivities are positive. In experiments, the initial concentration of receptors, 
x2(0), may be easier to vary than the rate constant, k7, the latter by mutation and the 
former by selecting the right cells with different numbers of insulin receptors. 
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Figure １３:  Grouping of sensitivity curves according to shape similarity in different 
mo-dules. Solid curves denote the results of the model with both the positive and 
negative feed-backs; dashed curves denote the results of the model without feedbacks; 
dotted curves de-note the results of the model with only the positive feedback; and 
dash-dotted curves de-note the results of the model with only the negative feedback.  
(A) ( )0ln
ln
2
21
xd
xd  and (B) 
7
21
ln
ln
kd
xd . 
  46
4.5 Effect of phenomenological assignment of reaction constants 
When the feedbacks are present, we note the presence of declining periods in the 
absolute values of the sensitivity curves shortly after the insulin is switched on. The 
declines last for a few minutes, depending on the feedback conditions.  As an example, 
we see in Figure 11A, in the positive-feedback-alone curve, the declining period is 
from 1.18 minute to 17.18 minute, for the negative-feedback-alone is from 0.54 minute 
to 3.47 minute, for both-feedback is from 0.53 minute to 4.27 minute. This 
phenomenon results from the upper bound set for the combined effect of the activated 
PKB/Akt (x18) and PKC-ζ (x19) in the Sedaghat model.  More specifically, the bound 
appears in the definition relation for the rate k13′, the insulin-stimulated GLUT4 
exocytosis rate. In those periods the formula ( ) ⎟⎠
⎞⎜⎝
⎛+
100
118.02.0 1917 xx  yields value ≥ 1 
and k13′ is scaled back. As shown in Figure 14, du-ring the same periods the 
concentration of intracellular GLUT4 (x20) decreases with time, thus the insulin-
stimulated flux contribution to the GLUT4 translocation process, i.e., k13′x20, decreases. 
This contributes to the declining periods mentioned above, which occur under the both-
feedback, negative feedback, and positive feedback cases, but not when there is no 
feedbacks.  
The phenomenological assignment on the reaction rate constant has significant 
consequences on the shapes of dynamic sensitivity curves.  It results in discontinuities 
in the sensitivity curves, which is an artificial effect of the present models. 
  47
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0 10 20 30 40 50 60 70 80 90 100
Time (minute)
k 1
3'
0
20
40
60
80
100
120
x 2
0 (
%
)
k13'
x20
(0.2x17 + 0.8x19)11%>1
 
Figure １４:  The saturation effect of k13′ between 0.53 minute to 4.27 minute in the 
model with feedbacks. ( ) ( ) ⎟⎠
⎞⎜⎝
⎛ +⋅−= 1,
100
118.02.0min9646040167.0 1917'13 xxk , in the 
above period the min(•) function  is the constant value 1 since ( )
100
118.02.0 1917 xx +  ≥ 1.  
This makes the related Jacobian elements 1720 xf ∂∂ , 1920 xf ∂∂ , 1721 xf ∂∂ , and 
1921 xf ∂∂ equal to zero. 
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Chapter 5:  Rankings of effectors and interactions as drug targets using 
sensitivities 
As in the cases of coupled mitogen-activated protein kinase and phosphoinositide 3-
kinase (MAPK-PI3K) pathways related to cancers [33, 36 ], we can make use of 
normalized sensitivities to rank potential drug targets in the present insulin pathways. 
For this purpose, we can use two derived quantities of sensitivities: integrated and local 
sensitivities. Integrated sensitivities can be obtained by integrating the sensitivities over 
a period of time and represent the accumulative or global effects of certain parameters. 
For local sensitivities, we just use the peak values of the time evolution curves of 
sensitivities. 
As mentioned earlier, the feedbacks (especially the negative feedback) induce 
the complex temporal behaviors of the sensitivities.  We refer again to Figures 10C and 
10D, which show the dimensionless sensitivities of the membrane GLUT4 to the initial 
concentration of the unactivated Akt and PKC-ζ, under all four feedback conditions 
(no-feedbacks, positive-feedback alone, negative-feedback alone, and both feedbacks).  
Because of the roles of positive and negative feedback loops, nonlinear property of the 
chemical kinetics of the reaction network, and the above mentioned limit of the overall 
metabolic effect of activated Akt and PKC-ζ in subsection 4.5, the curves under the 
four feedback conditions have very different peak values and transient shapes. Here 
below, we made rankings of the dimensionless sensitivities by the peak values of the 
sensitivity curves and the integrated dynamic sensitivities. The peak value rankings 
present the largest contributions of the parameters and initial concentrations to 
sensitivities of the membrane GLUT4 (local sensitivities), and the rankings of the 
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integrated sensitivities evaluate the overall contributions to the sensitivities of the 
membrane GLUT4 (global sensitivities) of certain parameters over an effective time 
range of insulin regulation (0 – 70 minutes). Global and local sensitivities yield similar 
rankings. In our submitted paper, we presented rankings of the integrated sensitivities 
[37].  Here we list the peak-value sensitivity rankings and the integrated-value sen-
sitivity rankings under no-feedback and both-feedback conditions. In Table 6, we 
present the rankings according to the peak values of the sensitivities for both the no-
feedback model (Table 6A) and the feedback model (Table 6B).  In Table 7, we present 
the rankings according to the integrated sensitivities for both the no-feedback model 
(Table 7A) and the feedback model (Table 7B). 
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Table 6:  Rankings of reaction rate parameters and initial concentrations by peak values 
of dimensionless sensitivities of membrane GLUT4.  (A) without feedbacks and (B) 
with feedbacks. 
 
A.  No feedbacks 
 
Order Parameter Peak time 
Peak 
sensitivity Description Module 
1 [PTP] 40.5 -1.7429
Phosphatase for phosphorylated 
insulin substrates, once-bound insulin 
receptors, and once- and twice-bound 
internal insulin receptors 
IR, IRS
2 x14(0) 70.0 1.7351 Initial concentration of PI(4,5)P2 GLUT4
3 [PTEN] 70.0 -1.7347 Phosphatase for the deactivation of PI(3,4,5)P3 to PI(4,5)P2 
PIP
4 k-9 70.0 -1.7347
Dephosphorylation rate of PI(3,4,5)P3 
to PI(4,5)P2 
PIP
5 k9 70.0 1.7123
Rate of phosphorylation of PI(4,5)P2 
to PI(3,4,5)P3 catalyzed by IRS-
1/PI3K complex 
PIP
6 k-13 46.0 -1.4732
Internalization rate of GLUT4 from 
plasma membrane to intercellular 
compartments 
GLUT4
7 k-3 41.5 -1.3045
Dephosphorylation rate of 
phosphorylated once-bound insulin 
receptors 
IR
8 x21(0) 0.0 1.0000
Initial concentration of membrane 
GLUT4 GLUT4
9 k13’ 1.0 0.9825
Insulin regulated translocation rate of 
GLUT4 from intracellular 
compartments to plasma membrane 
GLUT4
10 x20(0) 12.5 0.9467
Initial concentration of intracellular 
GLUT4 GLUT4
11 k13 70.0 0.9394
Translocation rate of GLUT4 from 
intracellular compartments to plasma 
membrane 
GLUT4
12 k12 1.0 0.7136 Phosphorylation rate of PKC-ζ PKC/Akt
13 x11(0) 3.0 0.6277
Initial concentration of unactivated 
PI3K 
PKC/
Akt
14 x9(0) 3.0 0.6015
Initial concentration of 
unphosphorylated IRS-1 IRS
15 k8 3.0 0.5985
Rate of activation and association of 
PI3K with phosphorylated IRS-1 IRS
16 k-8 3.5 -0.5790
Dissocciation rate of IRS-1/PI3K 
complex IRS
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17 x18(0) 3.0 0.5790
Initial concentration of 
unphosphorylated PKC-ζ 
PKC/
Akt
18 k-12 4.0 -0.5097
Dephosphorylation rate of activated 
PKC-ζ PIP
19 k-7 37.0 -0.4615
Dephosphorylation rate of 
phosphorylated IRS-1 IRS
20 k7 37.0 0.4074 Phosphorylation rate of IRS-1 IRS
21 x2(0) 37.0 0.4054
Initial concentration of unbound 
membrane insulin receptors IR
22 k11 1.0 0.1784 Phosphorylation rate of Akt IRS
23 x16(0) 3.0 0.1447
Initial concentration of 
unphosphorylated Akt 
PKC/
Akt
24 k-11 4.0 -0.1274
Dephosphorylation rate of activated 
Akt 
PKC/
Akt
25 x1(0) 1.0 0.1047 Initial concentration of insulin IR
26 k1 1.0 0.1040
Once-binding rate of membrane 
insulin receptors IR
27 k14 70.0 0.0677
Input flux constant of intracellular 
GLUT4 GLUT4
28 k-14 70.0 -0.0572
Degradation rate of intracellular 
GLUT4 GLUT4
29 k-10 1.5 -0.0254
Dephosphorylation rate of PI(3,4,5)P3 
to PI(3,4)P2 
PIP
30 [SHIP] 1.5 -0.0254 Phosphatase for the deactivation of PI(3,4,5)P3 to PI(3,4)P2 
PIP
31 k4' 39.5 -0.0252
Rate of endocytosis of once- or twice- 
bound insulin receptors IR
32 k10 3.0 0.0218
Rate of phosphorylation of PI(3,4)P2 
to PI(3,4,5)P3 
PIP
33 x13(0) 0.5 0.0060 Initial concentration of PI(3,4,5)P3 PIP
34 x15(0) 70.0 0.0051 Initial concentration of PI(3,4)P2 PIP
35 k-2 37.0 -0.0040
Unbinding rate of phosphorylated 
twice-bound membrane insulin 
receptors to become once-bound 
membrane insulin receptors 
IR
36 k2 37.0 0.0030
Binding rate of phosphorylated once-
bound membrane insulin receptors to 
become twice-bound membrane 
insulin receptors 
IR
37 k-4 37.0 0.0021
Rate of exocytosis of unbound insulin 
receptors IR
38 x6(0) 37.0 0.0020
Initial concentration of unbound 
insulin receptors IR
39 k3 1.5 2.65E-04
Unbinding and dephosphorylation rate 
of once-bound membrane insulin IR
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receptors 
40 k4 37.0 -6.96E-05
Rate of endocytosis of insulin 
receptors IR
41 k6 34.0 3.92E-05
Rate of dephosphorylation and 
unbinding of intracellular insulin 
receptors to become intracellular 
unbound insulin receptors 
IR
42 k-4’ 40.5 1.44E-05
Rate of exocytosis of once- or twice- 
bound insulin receptors IR
43 k-1 1.0 -8.31E-06
Unbinding of once-bound membrane 
insulin receptors IR
44 k5 37.0 2.48E-06
Synthesis rate of intracellular unbound 
insulin receptors IR
45 k-5 37.0 -2.59E-20
Degradation rate of intracellular 
unbound insulin receptors IR
B. Both feedbacks 
Order Parameter Peak time 
Peak 
sensitivity Description Module 
1 [PTP] 45.5 -2.2791
Phosphatase for phosphorylated 
insulin substrates, once-bound insulin 
receptors, and once- and twice-bound 
internal insulin receptors 
(feed-
back)
2 x14(0) 70.0 1.7118 Initial concentration of PI(4,5)P2 GLUT4
3 [PTEN] 70.0 -1.7117 Phosphatase for the deactivation of PI(3,4,5)P3 to PI(4,5)P2 
PIP
4 k-9 70.0 -1.7117
Dephosphorylation rate of PI(3,4,5)P3 
to PI(4,5)P2 
PIP
5 k9 70.0 1.6731
Rate of phosphorylation of PI(4,5)P2 
to PI(3,4,5)P3 catalyzed by IRS-
1/PI3K complex 
PIP
6 k-3 46.0 -1.6252
Dephosphorylation rate of 
phosphorylated once-bound insulin 
receptors 
IR
7 k-13 51.0 -1.3850
Internalization rate of GLUT4 from 
plasma membrane to intercellular 
compartments 
GLUT4
8 x21(0) 0.0 1.0000
Initial concentration of membrane 
GLUT4 GLUT4
9 x20(0) 13.5 0.9456
Initial concentration of intracellular 
GLUT4 GLUT4
10 k13 70.0 0.9149
Translocation rate of GLUT4 from 
intracellular compartments to plasma 
membrane 
GLUT4
11 k13’ 1.0 0.8696 Insulin regulated translocation rate of GLUT4
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GLUT4 from intracellular 
compartments to plasma membrane 
12 k-7’ 39.5 0.8312
Rate of serine-dephosphorylation of 
IRS-1 IRS
13 k12 0.5 0.7024 Phosphorylation rate of PKC-ζ PKC/Art
14 [PKC] 5.0 -0.6038 The negative feedback signal from activated PKC-ζ 
(feed-
back)
15 k-7 43.0 -0.4747
Dephosphorylation rate of 
phosphorylated IRS-1 IRS
16 Kd 28.0 0.4639
Dissociation rate of the negative 
feedback loop 
(feed-
back)
17 k-8 42.5 -0.4307
Dissocciation rate of IRS-1/PI3K 
complex IRS
18 x11(0) 42.5 0.4258
Initial concentration of unactivated 
PI3K IRS
19 k7 42.0 0.4251 Phosphorylation rate of IRS-1 IRS
20 k8 42.5 0.4245
Rate of activation and association of 
PI3K with phosphorylated IRS-1 IRS
21 x9(0) 42.5 0.4241
Initial concentration of 
unphosphorylated IRS-1 IRS
22 x2(0) 42.5 0.4230
Initial concentration of unbound 
membrane insulin receptors IR
23 n 34.0 0.4176 Hill coefficient of the negative feedback loop 
(feed-
back)
24 x16(0) 41.5 0.3286
Initial concentration of 
unphosphorylated Akt 
PKC/
Akt
25 k-11 41.5 -0.3203
Dephosphorylation rate of activated 
Akt 
PKC/
Akt
26 k7’ 7.0 -0.1924
Rate of negative feedback stimulated 
serine-phosphorylation of IRS-1 IRS
27 Vmax 7.5 -0.1924
Maximal velocity of the negative 
feedback 
(feed-
back)
28 k11 0.5 0.1827 Phosphorylation rate of Akt 
PKC/
Akt
29 k-12 45.0 -0.1212
Dephosphorylation rate of activated 
PKC-ζ 
PKC/
Akt
30 x1(0) 0.5 0.1198 Initial concentration of insulin IR
31 k1 0.5 0.1195
Once-binding rate of membrane 
insulin receptors IR
32 x18(0) 45.0 0.1093
Initial concentration of 
unphosphorylated PKC-ζ 
PKC/
Akt
33 τ 9.0 -0.0696 Time lag of the negative feedback loop 
(feed-
back)
34 k14 70.0 0.0675 Input flux constant of intracellular GLUT4
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GLUT4 
35 k-14 70.0 -0.0575
Degradation rate of intracellular 
GLUT4 GLUT4
36 k4' 44.5 -0.0314
Rate of endocytosis of once- or twice- 
bound insulin receptors IR
37 [SHIP] 0.5 -0.0145 Phosphatase for the deactivation of PI(3,4,5)P3 to PI(3,4)P2 
PIP
38 k-10 0.5 -0.0145
Dephosphorylation rate of PI(3,4,5)P3 
to PI(3,4)P2  
PIP
39 k10 0.5 0.0060
Rate of phosphorylation of PI(3,4)P2 
to PI(3,4,5)P3 
PIP
40 x13(0) 0.5 0.0056 Initial concentration of PI(3,4,5)P3 PIP
41 x15(0) 70.0 0.0050 Initial concentration of PI(3,4)P2 PIP
42 k-2 43.0 -0.0034
Unbinding rate of phosphorylated 
twice-bound membrane insulin 
receptors to become once-bound 
membrane insulin receptors 
IR
43 k2 43.0 0.0026
Binding rate of phosphorylated once-
bound membrane insulin receptors to 
become twice-bound membrane 
insulin receptors 
IR
44 k-4 43.0 0.0022
Rate of exocytosis of unbound insulin 
receptors IR
45 x6(0) 43.0 0.0021
Initial concentration of unbound 
insulin receptors IR
46 k3 0.5 6.63E-04
Unbinding and dephosphorylation rate 
of once-bound membrane insulin 
receptors 
IR
47 k4 43.0 -6.13E-05
Rate of endocytosis of insulin 
receptors IR
48 k6 40.0 3.85E-05
Rate of dephosphorylation and 
unbinding of intracellular insulin 
receptors to become intracellular 
unbound insulin receptors 
IR
49 k-4’ 45.0 2.20E-05
Rate of exocytosis of once- or twice- 
bound insulin receptors IR
50 k-1 0.5 -9.53E-06
Unbinding of once-bound membrane 
insulin receptors IR
51 k5 43.0 2.60E-06
Synthesis rate of intracellular unbound 
insulin receptors IR
52 k-5 43.0 -2.70E-20
Degradation rate of intracellular 
unbound insulin receptors IR
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Table 7:  Rankings of reaction rate parameters and initial concentrations using 
integrated sensitivities of GLUT4.  (A) without feedbacks and (B) with feedbacks. 
A. No feedbacks 
Order Parameter Value Description Module 
1 x14(0) 71.98 Initial concentration of PI(4,5)P2 GLUT4
2 k-9 -70.88 Dephosphorylation rate of PI(3,4,5)P3 to PI(4,5)P2 PIP
3 [PTEN] -70.88 Phosphatase for the deactivation of PI(3,4,5)P3 to PI(4,5)P2 
PIP
4 k-13 -66.85 
Internalization rate of GLUT4 from plasma 
membrane to intercellular compartments GLUT4
5 x20(0) 63.80 Initial concentration of intracellular GLUT4 GLUT4
6 k9 61.87 
Rate of phosphorylation of PI(4,5)P2 to 
PI(3,4,5)P3 catalyzed by IRS-1/PI3K complex  
PIP
7 [PTP] -49.64 
Phosphatase for phosphorylated insulin substrates, 
once-bound insulin receptors, and once- and 
twice-bound internal insulin receptors  
IR, IRS
8 k-3 -34.31 
Dephosphorylation rate of phosphorylated once-
bound insulin receptors IR
9 x11(0) 27.07 Initial concentration of unactivated PI3K IRS
10 x9(0) 26.31 Initial concentration of unphosphorylated IRS-1 IRS
11 k-8 -26.26 Dissocciation rate of IRS-1/PI3K complex IRS
12 k8 26.34 
Rate of activation of PI3K and association with 
phosphorylated IRS-1 IRS
13 k13 24.56 
Translocation rate of GLUT4 from intracellular 
compartments to plasma membrane GLUT4
14 x18(0) 23.87 Initial concentration of unphosphorylated PKC-ζ PKC/Akt
15 k-12 -22.50 Dephosphorylation rate of activated PKC-ζ PKC/Akt
16 k13′ 20.81 
Insulin regulated translocation rate of GLUT4 
from intracellular compartments to plasma 
membrane 
GLUT4
17 k-7 -15.34 Dephosphorylation rate of phosphorylated IRS-1 IRS
18 k12 15.22 Phosphorylation rate of PKC-ζ PKC/Akt
19 k7 14.30 Phosphorylation rate of IRS-1 IRS
20 x2(0) 14.24 
Initial concentration of membrane insulin 
receptors IR
21 x16(0) 5.97 Initial concentration of unphosphorylated Akt 
PKC/
Akt
22 k-11 -5.63 Dephosphorylation rate of activated Akt 
PKC/
Akt
23 x21(0) 3.99 Initial concentration of membrane GLUT4 GLUT4
24 k11 3.81 Phosphorylation rate of Akt PKC/
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Akt
25 k14 2.21 Input flux constant of intracellular GLUT4 GLUT4
26 k-14 -1.71 Decay rate of intracellular GLUT4 GLUT4
27 [SHIP] -0.74 Phosphatase for the deactivation of PI(3,4,5)P3 to PI(3,4)P2 
PIP
28 k-10 -0.74 Dephosphorylation rate of PI(3,4,5)P3 to PI(3,4)P2 PIP
29 k4’ -0.73 
Rate of endocytosis of once- or twice- bound 
insulin receptors IR
30 k10 0.72 
Rate of phosphorylation of PI(3,4)P2 to 
PI(3,4,5)P3 
PIP
31 k1 0.58 Once-binding rate of membrane insulin receptors IR
32 x1(0) 0.30 Initial concentration of insulin IR
33 x13(0) 0.23 Initial concentration of PI(3,4,5)P3 PIP
34 x15(0) 0.22 Initial concentration of PI(3,4)P2 PIP
35 k-2 -0.13 
Unbinding rate of phosphorylated twice-bound 
membrane insulin receptors to become once-
bound membrane insulin receptors 
IR
36 k2 0.10 
Binding rate of phosphorylated once-bound 
membrane insulin receptors to become twice-
bound membrane insulin receptors 
IR
37 k-4 0.07 Rate of exocytosis of unbound insulin receptors IR
38 x6(0) 0.06 Initial concentration of unbound insulin receptors IR
39 k4 -2.E-03 Rate of endocytosis of insulin receptors IR
40 k6 1.E-03 
Rate of dephosphorylation and unbinding of 
intracellular insulin receptors to become 
intracellular unbound insulin receptors 
IR
41 k3 1.E-03 
Unbinding and dephosphorylation rate of once-
bound membrane insulin receptors IR
42 k-4’ 4.E-04 
Rate of exocytosis of once- or twice- bound 
insulin receptors IR
43 k5 7.E-05 
Synthesis rate of intracellular unbound insulin 
receptors IR
44 k-1 -5.E-05 
Unbinding of once-bound membrane insulin 
receptors IR
45 k-5 -8.E-19 
Degradation rate of intracellular unbound insulin 
receptors IR
B.  Both feedbacks 
Order Parameter  Value Description Module  
1 [PTP] -66.31  
Phosphatase for phosphorylated insulin substrates, 
once-bound insulin receptors, and once- and 
twice-bound internal insulin receptors 
(feed-
back)
2 k-13 -65.41 
Internalization rate of GLUT4 from plasma 
membrane to intercellular compartments GLUT4
3 x20(0) 63.88  Initial concentration of intracellular GLUT4 GLUT4
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4 x14(0) 53.17 Initial concentration of PI(4,5)P2 GLUT4
5 k-9 -52.86 Dephosphorylation rate of PI(3,4,5)P3 to PI(4,5)P2 PIP
6 [PTEN] -52.86 Phosphatase for the deactivation of PI(3,4,5)P3 to PI(4,5)P2 
PIP
7 k9 48.48 
Rate of phosphorylation of PI(4,5)P2 to 
PI(3,4,5)P3 catalyzed by IRS-1/PI3K complex  
PIP
8 k-3 -43.88 
Dephosphorylation rate of phosphorylated once-
bound insulin receptors IR
9 k-7′ 32.73 Rate of serine-dephosphorylation of IRS-1 IRS
10 k13′ 24.10 
Insulin regulated translocation rate of GLUT4 
from intracellular compartments to plasma 
membrane  
GLUT4
11 k13 21.69 
Translocation rate of GLUT4 from intracellular 
compartments to plasma membrane  GLUT4
12 Kd 19.17 Dissociation rate of the negative feedback loop 
(feed-
back)
13 k-7 -17.37 Dephosphorylation rate of phosphorylated IRS-1  IRS
14 x11(0) 16.46 Initial concentration of unactivated PI3K IRS
15 k8 16.36 
Rate of activation and association of PI3K with 
phosphorylated IRS-1 IRS
16 k-8 -16.36 Dissocciation rate of IRS-1/PI3K complex IRS
17 x9(0) 16.35 Initial concentration of unphosphorylated IRS-1  IRS
18 k7 15.57 Phosphorylation rate of IRS-1 IRS
19 x2(0) 15.50 
Initial concentration of membrane insulin 
receptors IR
20 N 14.24 Hill coefficient of the negative feedback loop (feed-back)
21 x16(0) 13.08 Initial concentration of unphosphorylated Akt 
PKC/
Akt
22 k-11 -12.54 Dephosphorylation rate of activated Akt 
PKC/
Akt
23 k12 6.48 Phosphorylation rate of PKC-ζ  PKC/Akt
24 Vmax -5.90 Maximal velocity of the negative feedback 
(feed-
back)
25 k11 5.87 Phosphorylation rate of Akt 
PKC/
Akt
26 k7′ -5.75 
Rate of negative feedback stimulated serine-
phosphorylation of IRS-1 IRS
27 k-12 -4.16 Dephosphorylation rate of activated PKC-ζ PKC/Akt
28 x18(0) 3.99 Initial concentration of unphosphorylated PKC-ζ  PKC/Akt
29 x21(0) 3.90 Initial concentration of membrane GLUT4 GLUT4
30 [PKC] -2.80 The negative feedback signal from activated PKC- (feed-
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ζ back)
31 k14 2.22 Input flux constant of intracellular GLUT4   GLUT4
32 k-14 -1.76 Degradation rate of intracellular GLUT4  GLUT4
33 τ -1.06 Time lag of the negative feedback loop (feed-back)
34 k4’ -0.94 
Rate of endocytosis of once- or twice- bound 
insulin receptors IR
35 k1 0.48 Once-binding rate of membrane insulin receptors IR
36 k-10 -0.29 Dephosphorylation rate of PI(3,4,5)P3 to PI(3,4)P2 PIP
37 [SHIP] -0.29 Phosphatase for the deactivation of PI(3,4,5)P3 to PI(3,4)P2 
PIP
38 k10 0.27 
Rate of phosphorylation of PI(3,4)P2 to 
PI(3,4,5)P3 
PIP
39 x1(0) 0.22 Initial concentration of insulin IR
40 x13(0) 0.17 Initial concentration of PI(3,4,5)P3 PIP
41 x15(0) 0.16 Initial concentration of PI(3,4)P2 PIP
42 k-2 -0.11 
Unbinding rate of phosphorylated twice-bound 
membrane insulin receptors to become once-
bound membrane insulin receptors 
IR
43 k2 0.09 
Binding rate of phosphorylated once-bound 
membrane insulin receptors to become twice-
bound membrane insulin receptors 
IR
44 k-4 0.07 Rate of exocytosis of unbound insulin receptors IR
45 x6(0) 0.07 Initial concentration of unbound insulin receptors IR
46 k4 -2.E-03 Rate of endocytosis of insulin receptors IR
47 k6 1.E-03 
Rate of dephosphorylation and unbinding of 
intracellular insulin receptors to become 
intracellular unbound insulin receptors 
IR
48 k3 1.E-03 
Unbinding and dephosphorylation rate of once-
bound membrane insulin receptors IR
49 k-4’ 6.E-04 
Rate of exocytosis of once- or twice- bound 
insulin receptors IR
50 k5 8.E-05 
Synthesis rate of intracellular unbound insulin 
receptors IR
51 k-1 -4.E-05 
Unbinding of once-bound membrane insulin 
receptors IR
52 k-5 -9.E-19 
Degradation rate of intracellular unbound insulin 
receptors IR
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Examining the ranking tables, we see that the rankings of the peak values of 
sensitivities and the integrated sensitivities are similar under no-feedback and both-
feedback conditions. Since integrated sensitivity rankings presents the overall contri-
bution of the system parameter to the sensitivity of membrane GLUT4, we will focus 
on the investigation of integrated ranking lists.  The ranking list of the no-feedback 
model can be roughly summarized by the following ranking of modules: PIP > GLUT4 
> IRS > PKC/Akt > IR (Table 2A). For the model with feedbacks the order has 
changed to GLUT4 > PIP > IRS > PKC/Akt > IR (Table 2B). In both cases, the 
GLUT4 module and, the PIP module take the leading positions in the rankings.  The 
PIP module is essential in activating the protein kinases PKC-ζ and Akt, and the 
parameters in the GLUT4 module play direct roles in the translocation flow of GLUT4. 
Phosphatases [PTEN] and [PTP] rank high in both lists.  
In the no-feedback model, the concentrations of the upstream effectors are not 
affected by the reaction parameters in the downstream reactions.  The presence of 
feedback loops scrambles this simple upstream-downstream order of the network, 
because a feed-back loop feeds a downstream signal back to affect the upstream 
effectors.  As a result feed-backs make the dynamic behaviors of the sensitivities more 
complicated, as seen in Figures 8-13. One may therefore ask what the effects of feed-
backs on the rankings are.  It seems that, as the above lists show, the ranking order of 
the modules is not greatly affected, only that the GLUT4 module becomes relatively 
more important in the feedback model. 
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However, if we examine the ranking lists more closely, we do find the effects of 
feedbacks on sensitivities.  In the direct check of the absolute values of the integrated 
sensitivities, we see that sensitivity values of the parameters that are related to the 
positive feedback increase and those related to the negative feedback decrease. The 
promotion effect of the positive feedback can be seen in the sensitivities with respect to 
k-3, k11, k-11, [PTP], x2(0), and x16(0). Here not only the cumulative sensitivity values 
increase, but some move to higher positions in the list with feedbacks, compared to the 
list without feedbacks. The inhibition effect of the negative feedback can be found in 
the sensitivities of GLUT4 with respect to k8, k-8, x9(0), and x11(0) in the IRS-1 module, 
k9, k-9, [PTEN], and x14(0) in the PIP module, and k12, k-12, and x18(0) in the PKC/Akt 
module.  The parameters and effectors outside the feedback loops are not obviously 
affected.     
All the negative feedback parameters [PKC], Kd, Vmax, n, and τ in Equation (3.2) 
enter the feedback ranking list (Table 2B).  The feedback loops even raise the position 
of [PTP] to be the most important effector due to its multiple deactivation actions on 
the activated insulin receptors and IRS-1.  In the negative feedback loop, the activated 
PKC-ζ catalyzes the serine-phosphorylation of IRS-1, this makes less IRS-1 available 
for tyrosine phosphorylated and the subsequent activation of PI3K. The catalytic effect 
of PKC-ζ on serine-phsphorylation of IRS-1 is described by a Hill equation (3.2), 
containing parameters [PKC], Kd, n and τ.  These parameters play different roles in the 
sensitivity behaviors.  The linear coefficient Vmax has a negative sensitivity as that of 
[PKC], and so is the sensitivity with respect to the delay time τ.  The latter is negative, 
perhaps because at the value of τ = 1.5 minute, a positive perturbation to the time lag τ 
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makes a positive value change of PKC on the average.  The sensitivities to the dis-
sociation rate Kd and Hill coefficient n are both positive, since they help to impair the 
negative feedback effect, i.e., the [PKC] value is reduced when their values increase.  
In the negative feedback loop, the most important parameter is Kd.  Its pivotal role in 
controlling the oscillatory behaviors of the effector concentrations is illustrated in the 
paper under construction [38]. 
The two lists, Tables 2A and 2B, that rank the integrated sensitivities of 
membrane GLUT4 with respect to the effectors and their related reaction rate parame-
ters in the insulin pathways can, in some sense, be interpreted as a guideline to the po-
tential drug targets associated with the pathways.  It would be interesting to compare 
some of the predictions of the tables with the experimental facts and information on 
drug targets and drug leads available in literature. Ranking high in the list are phos-
phatases, protein tyrosine phosphatases (PTP) and PTEN. PTPs, in particular PTP1B, 
have been identified as potential drug targets in the literature [39,40,41]. Inhibitors of 
PTPs, such as vanadium and peroxovandium could be considered as drug leads. PTEN, 
however, is not a good drug target, although it does rank high in the tables (#3 and #6, 
respectively, in Tables 7A and 7B).  This is because PTEN is known to be a cancer 
suppressor [42,43,44].  Another phosphatase of PI(3,4,5)P3, SHIP, would have ranked 
#27 and #37 in the extended Tables 2A and 2B, respectively, and has also been 
implicated as a potential drug target based on experiments on mice models [45,46].  
The ranking of the polyphosphoinositide phosphatases, e.g., PTEN and SHIP, points 
out the important roles played by PI(3,4,5)P3 and PI(4,5)P2 in the pathways.  Indeed the 
phosphorylation and dephosphorylation rates and initial concentration related to these 
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proteins rank very high in the tables, so does PI3K, the kinase of PI(4,5)P2 phos-
phorylation.  So PI(3,4,5)P3, PI(4,5)P2, and PI3K should be important drug targets 
themselves, if their defects, such as, mutations, underlie the mechanisms of insulin 
resistance of diabetes patients.  Insulin receptors rank relatively high in the lists (#8, 
#19 and #20 in the tables) and have been considered as targets [39,47], yet so far small-
molecule drugs targeting receptors are still hard to come by.  The parameters associated 
with the negative feedback loop and PKC-ζ also appear in various positions in Table 
7B.  Indeed, as one of the serine and threonine-phosphorylation kinases, PKC is 
considered one of the potential drug targets in the literature [39].  In fact, the widely 
used drug for Type 2 diabetes, metformin, is found to in-crease the PKC activity, 
besides the activation of 5’-AMP-activated protein kinase [48]. 
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Chapter 6:  Control analysis applied to the delivery profile of insulin 
For a biochemical reaction network, we may be able to use the information of systems 
dynamics and time-dependent sensitivities to achieve certain control targets for the 
purpose of therapy or drug applications by adjusting a few parameters of the system. In 
a broad sense, this is related to metabolic control analysis (MCA) [49,50,51,52,53], 
developed mainly for the studies of metabolic pathways. But the control strategy we 
present here is more in line with the ideas of the control of chemical reactions 
[54,55,56,57], in which scientists direct reactions to proceed in such a way as to 
enhance certain products, for instance, by controlling a branching ratio.  This is often 
achieved by optimizing certain input profiles, such as laser pulse shapes in coherent 
control of chemical reactions [54].   
For the present biochemical network, the input profile could be the insulin 
delivery curve and the target reaction goal would be the time evolution of the 
concentrations of certain effectors.  Two general control schemes will be considered:  
The first focuses on the concentration of a target effector at a fixed time by adjusting 
certain parameters with the knowledge of sensitivity and concentration at that time to 
reach a target concentration of that effector.  This is called the time-point method.  The 
second is the time-integrated method, in which our target is an integrated concentration, 
which is achieved by using integrated sensitivity and concentration to determine the 
optimal value of a chosen parameter.  
Our target or control objective here is to improve the output curve shape of the 
plasma membrane GLUT4, for example, to increase the duration of the high concen-
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tration period of membrane GLUT4. The biological importance of this is that an 
increased concentration of membrane GLUT4 can improve the uptake of glucose from 
bloodstream into the tissue cells.  The parameter to be adjusted is a parameter related to 
the insulin dosage.  We require that the control goal be achieved at a fixed total amount 
of insulin input. 
6.1 Control of a time-point concentration  
In this control scheme we assume that at a certain time point we require that the 
concentration of membrane GLUT4 to be at a certain prescribed value.  This control 
target will be achieved by adjusting the insulin delivery profile.  We have noticed [38] 
that the shape of the dosage curve can make a big difference to insulin efficiency in 
stimulating GLUT4 exocytosis.  Therefore, in this section we consider continuous 
distributions, such as Gaussian function, instead of the square function considered by 
Sedaghat, et al. [17].  The control parameter to vary for achieving the target is thus a 
parameter related to the shape of the insulin delivery profile.  
A simple method, among many options, to find the value of the control 
parameter p approaching and reaching the target is the Newton-Raphson iterative 
scheme [58], given below,  
 ( ) ( )
i
i
iiiii dp
pdf
pfppp −=+=+ δ1 ,      (6.1) 
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where f(p) is the difference between the target concentration and the actual concen-
tration at the prescribed time t, 
( )
i
i
dp
pdf
 is the sensitivity at that time. δi is the ad-
justment at the ith iteration step for parameter p.  
 The rate of convergence of the iterative scheme depends on the ratio of the con-
centration and the sensitivity ( ) ( )
i
i
i dp
pdfpf  in Equation (6.1).  For a fixed difference 
between the actual concentration and the target concentration , the iteration 
improvement for pi, δi, is small when the sensitivity is large.  In our experience, for a 
step function dosage the value of the sensitivity of membrane GLUT4 with respect to 
input concentration is of the order of 105 to 106, so the iteration has a very low 
efficiency.  Out experience shows that for a target concentration of membrane GLUT4 
to be 10 percent, the iteration takes up to more 30.  On the other hand, the sensitivity of 
concentration of membrane GLUT4 with respect to the standard deviation of a 
Gaussian insulin input function is much smaller (~ 10-2 to 10-3), therefore, the iteration 
efficiency is much more improved.  As our result will show  later, the actual Gaussian 
insulin delivery control only takes 4 to 6 iteration steps.  The Gaussian function we 
used for insulin delivery is  
( )ipf
 2
2
2
1 2
2 σ
πσ
t
eDx
−= ,        (6.2) 
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where D is the fixed integrated insulin dosage, σ is the standard deviation, t is time.  
Details about how to derive the expression of the Gaussian delivery can be found in the 
later subsection 9.2.   
For a target concentration of membrane GLUT4, the number of iteration steps is 
never larger than five.  Two examples are shown in Figures 15A and 15B, where the 
target time is at 61 minutes in Figure 15A and 71 minutes in Figure 15B from the 
starting time of insulin injection, results converge in just 3 iteration cycles to a desired 
concentration (15%) in Figure 15A and just 5 iteration cycles to a desired concentration 
(10%) in Figure 15B.  In this model, the iterative values approach the target value in an 
oscillatory way.  
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Figure １５:  Time-point concentration control. The target integrated concentrations of 
membrane GLUT4 are 15 % at 61 minute in case (A) and 10 % at 71 minute in case 
(B).  Standard deviations (STD) of Gaussian time distribution of the input insulin 
concentration are varied in intermediate Newton-Raphson iteration steps with the 
integrated insulin do-sage kept constant (10-7 M × 15.0 min). Iterations start at STD = 
10.0 minute and arrive at the objective curves at STD = 12.70 min (A) and 13.93 min 
(B).  Intermediate steps are also shown. 
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 The oscillatory iteration convergence of the time-point concentration control 
originnates from the sinusoidal time-point concentration of membrane GLUT4 at the 
target time under different standard deviations of Gaussian insulin delivery functions.  
The convergence depends significantly on the guess of the starting standard deviation 
value and the target concentration.  Figure 16 shows the schematic convergence 
processes of the iteration under different guesses of the starting standard deviations.  In 
Figure 16A the starting standard deviation result in an oscillatory convergence behavior.  
Figure 16B shows the wrong convergence, in which the iteration goes to the slow de-
creasing part of concentration of membrane GLUT4 and results in a very large standard 
deviation in order to reach the target concentration. Figure 16C shows the monotonic 
convergence for a good guess of the starting standard deviation. 
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Figure １６:  Iteration processes of different target concentration and starting standard 
deviations in time-point concentration control strategy.  (A) is the oscillatory conver-
gence, (B) is the wrong convergence, (C) is the monotonic convergence. 
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6.2 Control of a time-integrated concentration 
A more practical control target for insulin applications may be the total amount of 
membrane GLUT4 integrated over a fixed time period, because it is related to the total 
amount of glucose transported into tissue cells.  Therefore, in this subsection, in the 
second control scheme we set as target an integrated amount of membrane GLUT4 
over a fixed period of time.  In this control of time-integrated concentration method, the 
function f is the difference between the integrated and the desired cumulative 
concentration of membrane GLUT4, 
( ) ( )TtIdttxf T
t
,−= ∫ ,       (6.3) 
where t and T are the lower and upper limits of the integration time period, and ( )TtI ,  
is the target cumulative concentration. Thus the Newton-Raphson iterative steps for the 
parameter p becomes  
( ) ( ) ( )∫∫ ∂∂⎥⎦⎤⎢⎣⎡ −−=+
T
t
i
T
tii
ds
p
sxTtIdssxpp ,1     (6.4) 
As in subsection 5.1, we consider a continuous insulin dosage curve in the form 
of a Gaussian distribution and treat the standard deviation of the Gaussian time-
distribution as the control parameter.  Two such examples of time-integrated control 
are given in Figures 17A and 17B, where the lower and upper limits of the integration 
time is t = 0 and the tar-get time, T and the target integrated concentrations are 1600% 
at T = 61 minute (Figure 10A) and 2000% at T = 71 minute (Figure 17B).  Figure 17 
shows that the iterative results approach the target curve monotonically, not in an 
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oscillatory fashion as in Figure 15.  The monotonic convergence process originates 
from the monotonic increase of the integrated concentration of membrane GLUT4 
before the integration from 0 to 61 minute reaches its maximal value of about 1958 
percent⋅minute.  The iteration process is schematically illustrated in Figure 18.  For the 
same starting standard deviation, it is natural to take more iteration steps to converge 
for larger target values, but our empirical results show that in all cases studied, the 
iterations take just a few steps to reach the targets. 
Time-point concentration control makes use of the concentration and sensitivity 
information at a specific time T.  Therefore, the control performance is heavily depen-
dent on the local values at that time.  Time-integrated control takes the cumulative 
values of concentration and sensitivity in a time period, thus the method results in more 
robust and consistent iteration behaviors.  In reality, both the time-point and time-
integrated control methods are limited by the available improvement values.  That is, 
the targets should be reasonable, for example, we can not make a target concentration 
of membrane GLUT4 higher than its maximum effective value (~ 35%), which is the 
result of the full stimulated concentration when a continuous insulin input concen-
tration 10-7 M, for the time-point control and we can not make a target integrated 
concentration larger than the available area, which is the difference of the maximum 
concentration of membrane GLUT4 and its actual concentration integrated over the 
time period.  Figure 19 shows the improvement limits for both the time-point control 
concentration and the time-integrated control concentration.  For the target time at 61 
minute, the available concentration improvement for membrane GLUT4 in time-point 
control is from 4.72 percent to 34.66 percent, the available cumulative-concentration 
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improvement for membrane GLUT4 is 784.85 percent⋅minute, i.e., the target time-
integrated concentration is in the range 964.84 percent⋅minute to 1746.48 
percent⋅minute.  For the target time at 71 minute, the time-point concentration limits is 
4.19 percent to 34.70 percent, the time-integrated concentration limits is from 968.74 
percent⋅minute to 2053.48 percent⋅minute.  Another note about the time-integrated 
control is that the target time-integrated concentration is just the cumulative concen-
tration in the target time period, but the actual integrated overall concentration of 
membrane GLUT4 is much more improved.  In Figure 17A, the actual integrated 
overall concentration of membrane is 2203.22 percent⋅minute, much larger than the 
1600 percent⋅minute target integrated concentration in the 0 – 61 minute period.  In 
Figure 17B, the actual integrated overall concentration of membrane is 3093.56 
percent⋅minute, much larger than the 2000 percent⋅minute target integrated concen-
tration in the 0 – 71 minute period. 
Finally, we noticed that the continuous insulin dosage profile is more 
representative of the real situations than the step function, for instance, clinical evi-
dence shows that the insulin release pattern after fasting is indeed a continuous curve 
[59]. Furthermore, recently, the insulin pump has been used as a dosage machine to 
deliver programmable insulin levels for individual patients [60]. Therefore, it seems 
possible that similar devices can be developed to realize the control of insulin delivery 
according to patient’s glucose level in the blood-stream.  On this goal the present study 
has taken a small first step. 
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Figure １ ７ :  Time-integrated concentration control. The target integrated 
concentrations of membrane GLUT4 are 1600 min% at 61 minute in case (A) and 2000 
min% at 71 minute in case (B).    Standard deviation (STD) of Gaussian time 
distribution of the input insulin concentration is varied in intermediate Newton-
Raphson iteration steps with the integrated insulin dosage kept constant (10-7 M × 15.0 
min). Iterations start at STD = 10.0 minute and arrive at the objective curves at STD = 
15.02 min (A) and 28.52 min (B).  Inter-mediate steps are also shown. 
  75
0500
1000
1500
2000
2500
0 20 40 60 80 100 120 140 160 180 200
Standard deviation (minute)
 In
te
gr
at
ed
 c
on
ce
nt
ra
tio
n 
(%
)
Integrated GLUT4
Target integrated 
concentration
Starting STD
 
Figure １８:  Iteration process of time-integrated concentration control strategy. The 
integration of the concentration of membrane GLUT4 results in a monotonic curve of 
the cumulative concentration with respect to the standard deviation. Therefore, the con-
vergence of the iteration is also monotonic. 
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Figure １９:  Target concentration limits of time-point and time-integrated control 
strategies. At 61 minute, the available target-concentration of membrane GLUT4 for 
time-point control is from 4.72 percent to 34.66 percent, the available target-integrated-
concentration of membrane GLUT4 for time-integrated control is from 946.84 
percent⋅minute to 1746.79 percent⋅minute.  
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Chapter 7:  Non-equilibrium thermodynamic analysis 
On an extended horizon than the studies of thermo properties of a system, thermo-
dynamics is the physical science focusing on the deterministic reasons for the relation 
of system state properties. For the phenomenological models of insulin regulated 
GLUT4 network, there is still a lack of detailed kinetic information, thus a potential 
paradigm shift is to be made to the thermodynamic state parameters. Starting from 
dynamic flux analysis, we investigate chemical affinities, and entropy production rates 
(EPRs) to gain dynamic signaling information transfer, that is, the backflow caused by 
the removal of insulin under the different feedback conditions, in the concerned the 
insulin network.   
7.1  A brief review of non-equilibrium thermodynamics 
A complex chemical reaction network is composed of multiple reactions.  Suppose 
there are ρ reversible reactions in the network, for the ith reaction with n components 
1 1 2 2 ( 1) 1 ( 1) 1... ...
i
i
k
i i il l i l l i n n ink n
x x x x x xν ν ν ν ν ν+
− + + − −
+ + + + +ZZZXYZZZ  
where xj (j = 1, 2, …, n) is the molar concentration and νij is the stoichiometric 
coefficient of the jth component in the ith reaction.  νij takes a negative value for the 
reactant and a positive value for the product. k+ and k- are forward and backward 
reaction rates, respectively. 
1) Flux 
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Flux is the contribution term to the reaction rate of a reaction component 
dt
dxi . For the 
reversible reaction above, the forward flux 
∏
=
−
++ =
l
j
jii
ijxkJ
1
ν ,         (7.1) 
the backward flux  
∏
+=
−− =
n
lj
jii
ijxkJ
1
ν ,         (7.2) 
the net flux is the subtraction of the forward flux and backward flux,  
−+ −= iii JJJ .         (7.3) 
The net flux is positive for a forward dominant reaction, negative for a backward 
dominant reaction, and zero for a chemical equilibrium. 
2) Chemical affinity   
In the ideal solution model, chemical affinity is represented by [61] 
∑−=
j
jiji vA μ         (7.4) 
where μj (j = 1, 2, …, n) is the chemical potential or molar Gibbs free energy of the jth 
component.  
Under the ideal solution approximation μj = μj0 + kBTlncj, μj0 is thermal 
potential of standard state and cj = xj/xT (xT = x1 + x2 + … + xn is the total concentration) 
is the fractional concentration of the jth component. Therefore, 
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At equilibrium, both the net flux and the chemical flux are zero, i.e., Ji+,eq = Ji-,eq and Ai 
= 0. So we have 
  0ln
eq,
eq, =
−
+
i
i
J
J
,          (7.6) 
and 
0lnln
11
0 =⎟⎟⎠
⎞
⎜⎜⎝
⎛+−−
+
−
==
∑∑
i
i
B
n
j
TijB
n
j
jij k
k
TkxTk νμν .    (7.7) 
Therefore,  
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The relation between the ratio of +− ii kk  and the equilibrium constant of the ith 
reaction is 
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ν
.    (7.9) 
The last expression in (7.9) comes from the fact that the change of the Gibbs 
free energy of the standard state is the stoichiometric sum of the chemical potentials of 
the standard states of the chemical species taking part in the reaction, 
 .        (7.10) ∑
=
=Δ
n
j
jijiG
1
00 μν
For a reaction with equal chemical stoichiometric reactions and products, 
. The simplest example is the isomerism 0
1
=∑
=
n
j
ijν
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A BZZXYZZ , 
where νA = -1 and νB = 1.  The equilibrium constant and the ratio of the reaction rate 
constants is 
+
−=
i
i
AB k
k
K . 
Chemical affinity can then be expressed as 
⎟⎟⎠
⎞
⎜⎜⎝
⎛=
−
+
i
i
Bi J
J
TkA ln .                                                                                          (7.11) 
This formula states that Ai is positive for a forward-dominating reaction, negative for a 
backward-dominating reaction and zero at chemical equilibrium. 
3) Entropy production rate (EPR) 
For the ith chemical reaction in the reaction network, EPR is given by:  
−
+
−+ −==
i
i
iiBii
i
J
JJJTkJA
dt
dS
ln)(
'
,      (7.12) 
where  denotes the dissipated heat generated in the ith reaction.  For a biochemical 
network, by summing over all reactions, the EPR for the network is given by 
'
iS
∑∑
==
===
ρρ
11
''
i
ii
i
i JA
dt
dS
AJ
dt
dS .      (7.13) 
If one assumes that the second law of thermodynamics holds even for non-equi-
librium systems discussed in this work, then EPR is always positive for reactions 
involved in signaling processes, which are not in equilibrium in general. This results in 
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increasing entropy as the system propagates. The only case for zero EPR is when the 
system is at chemical equilibrium. There have been, however, debates in the literature 
about the validity of second law for systems far from equilibrium. In fact, counter-
examples to the second law have been found for non-equilibrium systems. Furthermore, 
recent fluctuation theorems give explicit expressions for the probability of the second-
law-violating trajectories, this probability goes to zero exponentially in the long-time 
and/or macroscopic size limits.  The justification of the validity of the second law in the 
present network system may reside in the macroscopic averaging over a cell as well as 
many cells observed in the experiments. 
7.2  Applications of non-equilibrium thermodynamics to the insulin models  
Following Sedaghat, et al. [17], we consider in this subsection the application of insulin 
at a constant concentration for 15 minutes, before it is removed.  After the insulin 
removal at 15 minutes, most of the concentrations return to their original concen-
trations exponentially in biologically meaningful time scale (~ 60 minutes) except for 
the concentration of unbound intracellular insulin receptors (x6), because of its rela-
tively larger synthesis flux than that of degradation to be discussed in subsection 7.3.  
The non-steady state behavior of x6 affects other species through the reversible reaction  
4
4
2 6
k
k
x x
−
ZZZXYZZZ . 
Figure 20 shows the net flux in this reversible reaction.  There is a backward net 
flux of about 8.8 × 10-17 M/min from the intracellular receptor (x6) to the plasma mem-
brane receptor (x2) at a much longer time after the removal of insulin.  But this flux is 
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ignorable, because after about 60 minute times, the concentration of x2 has recovered to 
its original concentration 9.0 × 10-13 M, which is 4 orders of magnitude larger than that 
of the backward flux.  Another effector subjected to synthesis and degradation fluxes is 
the intracellular GLUT4 (x20).  It has a constant input flux k14 = 0.11088 min-1 and a 
degradation rate  k-14 = 0.001155 min-1.  Here the degradation has a much shorter life 
time (1/k-14 = 865.8 minutes), still much larger than insulin regulation time (about 60 
minutes) on which we are focusing.  However, Figure 21D shows that the concentra-
tion change of x20 brought by the synthesis and degradation is only as large as about 1 
percent of its concentration.  Therefore, except for x6 in the insulin receptor module, all 
other species exponentially approach a non-equilibrium steady state (NESS) in a 
physiologically meaningful time.  Time evolutions of concentrations of some effectors 
including x6 are shown in Figure 21.  An interesting observation here is that the 
associated flux and the affinity curves dip below the zero value after insulin is switched 
off, implying the existence of back flow of surface GLUT4 as shown Figure 22.  This 
could be understood in terms of the Le Chatelier Principle, i.e., removal of insulin 
causes backflow of the GLUT4 translocation reaction, which leads to the reduction of 
membrane GLUT4.  Each of the curves in Figure 22A is the net flux, which is the sum 
of the forward and backward fluxes.  Due to the second law of thermodynamics, EPR 
remains positive, but it shows a broad secondary peak at a time corresponding to 
backflow.  The backflow corresponds to the decrease of the concentration of membrane 
GLUT4, thus to the reduction of insulin efficiency.  In Chapter 9, we will address the 
question of how to increase insulin efficiency by reducing or delaying the backflow.  In 
Figure 22, the results for the GLUT4 exocytosis process are shown in four feedback 
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cases (no feedbacks, positive feedback, negative feedback and both positive and 
negative feed-backs).  At least for this process we see that positive-feedback and no-
feedback curves are smoother and close to each other, and negative-feedback and both-
feedback behave similar to each other and both show oscillatory behaviors in flux, 
affinity, and EPR.  Thus these results show that, for GLUT4, negative feedback loop 
plays a more important role than positive feedback loop in the model with both 
feedbacks. 
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Figure ２０:  The net flux in the reversible translocation between the membrane insulin 
receptors and the intracellular insulin receptors under the four feedback conditions.  
The negative values imply that the translocation is an exocytosis-dominant process.  
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Figure ２１:  Time evolutions of effector concentrations before and after the removal 
of insulin at 15 minute in the insulin input concentration, ranging from 10-11 M to 10-7 
M. The presented concentrations are: (A) membrane unbound insulin receptors (x2), (B) 
intracellular unbound insulin receptors (x6), (C) unactivated PI3K (x11), and (D) 
intracellular GLUT4 (x20). Except for x6, all other species can reach a non-equilibrium 
steady state.  
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C. Entropy production rate (EPR) of GLUT4 translocation process 
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Figure ２２:  Flux (A), chemical affinity (B), and entropy production rate (EPR) (C) of 
the GLUT4 translocation process under all the four feedback conditions.  Insulin input 
concentration is 10-7 M and removed at 15 minute.  
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One may ask whether we will see backflows for other reactions in the network 
when insulin is switched off.  We discuss this below, starting with the insulin receptor 
module. 
In the insulin receptor module, there are several specific properties of the 
reactions. One is that there are very large differences between the forward and 
backward reaction rates, the big differences have significant effects in the reactions.  
An example of this case is the reversible reaction of once-binding of insulin (x1) with 
the membrane insulin receptors (x2) to produce the once-bound membrane insulin 
receptors (x3),  
 
1
1
1 2
k
k 3
x x x
−
+ ZZZXYZZZ , 
the binding rate k1 = 6 × 107 M/min is much larger than the unbinding rate k-1 = 0.20 
min-1, but since the forward flux is the quadratic term k1x1x2 and the backward flux is 
the linear term k-1x3, removal of insulin results in x1 = 0, so the forward flux vanishes.  
At the same time, the phosphorylation rate of x3 to become x5 is also very large, k3 = 
2,500 min-1 but the PTP catalyzed dephosphorylation and unbinding with insulin of x5 
is very slow with the rate k-3 = 0.20 min-1 and the product is going back effectively to x2, 
so x3 is converted very rapidly to its phosphorylated form (x5) and its concentration 
drops very rapidly down to zero.  Therefore, the backflow, the unbinding of x3, with the 
rate equal to k-1x3, also drops to zero immediately.  The overall reaction of insulin once-
binding process effectively stops by with removal of insulin.  Another example is the 
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reversible twice-binding of x5 to become the phosphorylated twice-bound mem-brane 
insulin receptors (x4), 
 
2
2
1 5
k
k 4
x x x
−
+ ZZZXYZZZ . 
Again, the forward rate is k2 = 6 × 107 M/min, much larger than the backward rate k-2 = 
20 min-1.  However, the forward flux is determined by the quadratic term k2x1x5 and the 
backward flux is by the linear term k-2x4.  Although the net flux is relatively large (to 
the order of 10-13 M/min) immediately after the insulin is switched on, it drops to a 
very small value (to the order of 10-17 M/min) along with the constant insulin input.  
The removal of insulin results in x1 = 0, so the forward flux vanishes, but the backward 
flux still exists.  The back-flux is relatively large first, which consumes most of the 
concentration of x4, followed by a decreasing weak value (the starting value is ~ 10-19 
M/min and becomes exponentially small later).   
Another specific property in the IR module is that there are four reactions 
treated as irreversible. Apart from the two above mentioned phosphorylation of x3 to x5 
and dephosphorylation x5 to x2, there are two other dephosphorylation and insulin-
unbinding reactions  
6 [ ]
7 6
k PTPx x⎯⎯⎯→ , 
and 
6 [ ]
8 6
k PTPx x⎯⎯⎯→ . 
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In these cases the only existing one-way fluxes obviously dominate the reaction process.  
After the removal of insulin, the fluxes decrease exponentially to zero along with time. 
Even for comparably close values of the reaction rates of the reversible 
reactions, the net flux is basically determined by one direction.  The fluxes of the tran-
slocation of unbinding insulin receptors between x2 and x6 in Figure 21 is one example.  
The other two examples are the translocations of the phosphorylated once- and twice-
bound insulin receptors, i.e., between the two pairs x4 and x7, and x5 and x8.  
Therefore, the insulin cut-off effect, the one-way dominant flux and/or reaction 
scheme effect result in the zero flux and/or the atypical backflow properties in the IR 
module, which is not a characteristic feature of reversible reactions.  As we can see 
below, in the subsequent modules, the removal of the insulin triggers significant back-
flow in the reactions, a reflection of the Le Chatelier Principle, which states that if a 
chemical equilibrium is disturbed by a change of the concentration of some reaction 
components, the system will counteract the change by moving to a new equilibrium.   
In the subsequent modules, the reactions are reversible.  The difference between 
the forward and backward fluxes gives the net flux.  The back flows caused by the 
removal of insulin are more observable.  We have examined the forward flux, back-
ward flux and the net flux of the reactions and found out that most of the forward and 
backward fluxes of effectors in the same reversible reactions have very similar flux 
curve shapes. But there are three exceptions: the exocytosis and endocytosis of GLUT4; 
the synthesis and degradation fluxes of intracellular GLUT4 (x20) and the negative 
feedback stimulated serine-phosphorylation and it inverse reaction. The net flux is the 
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difference between each forward and backward flux pair of the same reaction.  Figure 
23 shows the dynamic forward flux, backward flux, and net flux of the phosphor-
rylation and dephosphorylation of PI(3,4)P2 to be-come PI(3,4,5)P3.  The forward flux 
and backward flux are very similar in shape.  The net flux results from the small time 
displacement between the forward flux and backward flux.  Initially, the switching-on 
of insulin bring about a increase of the concentration of PI(3,4)P2, corresponding to the 
negative net-flux before 2.5 minute, which is also the peak time of the concentration of 
PI(3,4)P2.  After that the concentration drops down, which is caused by the negative 
backflow of the reaction between 2.5 minute and 7 minute.  At 7 minute the con-
centration reaches its trough value.  Then the net flux is positive, this makes the con-
centration increase to its second peak value at about 12 minute.  Next is the negative 
net-flux which makes another drop-down of the concentration.  The oscillatory beha-
vior is stopped by the removal of insulin at 15 minute, which results in a small negative 
flux and a slow exponential decrease of the concentration of PI(3,4)P2. 
It is the perturbation caused by the feedback loops that induces transient 
oscillations, later in Chapter 8 we will show that the oscillations are triggered by nega-
tive feedback.  As we have seen in Figure 23, the periodic increase and decrease of os-
cillation behavior of concentration corresponds to the positive and negative net-flux, 
respectively.  The sign change increases the complexity of the dynamic flux behavior.  
Similar results are also shown in Figure 24, which shows the net-fluxes of the phos-
phorylation/dephosphrylation of IRS-1 and PKC-ζ under all the feedback conditions 
(no feedbacks, positive feedback alone, negative feedback alone, and both feedbacks).  
In case of no-feedback and positive-feedback-alone, the negative feedback is switched 
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off, the oscillations disappear and the fluxes damp to zero at about 2.5 minute until the 
insulin removal at 15 minute, which results in negative net-fluxes under all feedback 
conditions. 
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A. Concentration of PI(3,4)P2 
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B. Forward flux (J14+), backward (J14-), and net flux (J14) of the phosphory-
lation/dephosphorylation of PI(3,4)P2 
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Figure ２３ :  The forward flux, backward flux and net flux of the PI(3,4)P2 
phosphorylation reaction to become PI(3,4,5)P3 under both feedbacks. The forward and 
backward fluxes are very similar in shape but have a very small time displacement. The 
net flux is the difference between the forward flux and backward flux. 
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A. Fluxes of the IRS-1 phosphorylation/dephosphorylation process 
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B. Fluxes of PKC-ζ phosphorylation/dephosphorylation process 
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Figure ２４:  Examples of the insulin-removal effect in the reactions in the IRS and 
PIP modules. (A) is the flux of the flux in the reversible phosphorylation 
/dephosphorylation process of IRS-1, (B) is the flux of the reversible phosphorylation 
/dephosphorylation process of PKC-ζ.  
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In the translocation process of GLUT4, further studies show that one of the 
effects of the feedbacks seems to delay and reduce the backflow induced by insulin 
removal to a certain extent.  In terms of EPR we show Figure 25 that if we continue to 
apply insulin the backflow disappears and that without feedbacks the backflow is much 
larger.  Furthermore, Figure 25 shows the EPR peak is delayed from about 32 minute 
when there are no feed-backs to 39 minutes when there are feedbacks and the peak 
value is almost half reduced from about 0.90 kBT/min to about 0.48 kBT/min.  The total 
entropy production (i.e., the integrated EPR) by backflow also decreases from about 
15.87 kBT to 10.01 kBT, a reduction ratio of about 63 percent.  In the same diagram the 
EPR curves with and without feedbacks when there is continuous insulin stimulation 
are also presented.  In these cases the EPR curves exponentially reduces to zero at 
about 15 minute, which implies that the reaction achieves a quasi-equilibrium steady 
state and reaches the peak concentration after 15 minute. 
We have also studied the effect of varying insulin removal time (15 minutes, 25 
minutes, and 40 minutes) and investigated the backflows. The shapes of the EPR 
curves for the cases of no-feedback and both-feedback remain about the same values 
except for the peaks being lowered and shifted rightward (Figure 26).  In Table 8, the 
total amounts of entropy production, which is the integration of entropy production rate 
in the insulin regulation duration, in the GLUT4 translocation process for the 6 cases in 
Figure 26 are listed.  The feedback reduction ratios, which are ratio of the entropy 
production with both feedbacks and without feedbacks of the GLUT4 translocation 
process, are also enlisted.  There are insignificant changes of the entropy production 
with or without feedbacks respectively, and the EPR deduction ratios.  The biomedical 
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implication is that the removal of insulin will have the side effect of backflow no 
matter how long the steady state has been reached. The only way to avoid backflow is 
to keep applying the insulin at some level.  In our insulin delivery study reported in 
Chapter 9, we set it as a goal to delay and reduce the backflow of the GLUT4 
translocation to the membrane by varying the functional form of the dosage curve. 
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Figure ２５:  Feedback effect on the entropy production rate (EPR) of GLUT4 translo-
cation process. When there is no removal of insulin, there are no transient oscillations 
from 5 to ten minutes. The removal of the insulin at 15 minute induces backflows in 
both the no-feedback and both-feedback cases. The differences of the backflows 
between the no-feedback and both-feed-back cases are in the peak value and time: the 
peak value of both-feedback is lower than that of no-feedback, and the peak time is 
delayed.  
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Figure ２６:  Effects of insulin removal time on backflow in both no-feedback and 
both-feedback conditions. The cumulative EPR of the backflows when insulin is re-
moved at 15 minute, 25 minute, and 30 minute change slightly under no-feedback, so is 
the case under both-feedback. 
 
 
 
 
 
 
Table 8:  Entropy production at different insulin removal time. 
Insulin removal 
time (minute) 
Entropy production 
without feedback 
(kBT) 
Entropy production 
with feedbacks 
(kBT) 
Reduction ratio of 
entropy production 
(%) 
15 15.88 10.03 63.16 
25 16.06 10.21 63.57 
40 16.14 10.02 62.08 
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7.3 Effects of continuous insulin application  
For the study in this section, continuous application of insulin means that the input flux 
of insulin is adjusted to keep the insulin concentration outside the cell to be at a cons-
tant value of 10-7 M. Under the continuous stimulation of insulin, the concentrations of 
the effectors first approach the transient maximal or minimal values at different times 
[17].  As the reactions proceed, due to the synthesis and degradation fluxes on the 
intracellular insulin receptors (x6) and (x20), the concentrations of most species will not 
approach steady-state values in the meaningfully biological time period.  Specifically, 
the synthesis flux to x6 is of the order of 10-16 M/min, the degradation flux is of the 
order of 10-31 M/min.  Although the input flux is greater than the degradation flux, it is 
still much smaller than the initial concentration of x6 (10-13 M).  Therefore, concen-
tration of x6 increases very slowly.  In the case of x20, the synthesis flux is constant 
0.11088 %/min, the degradation flux is 0.001155x20, which takes the shape of x20, but 
always lower than the straight line of the synthesis flux.  This results in a net time-
dependent input and changes of the x20 concentration with time.  As a result of increase 
the concentration of x21 will not reach a non-steady-state, either.  In Figure 27 we show 
time-dependence of the concentrations of x6, x20, and x21 under the no-feedbacks, 
positive feedback alone, negative feedback alone, and both feedbacks.  It is clear that 
the reaction network that we are studying is an open system and does not have an 
equilibrium or steady state. 
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Figure ２７ :  Concentrations of (A) x6, (B) x20, and (C) x21 under all feedback 
conditions, showing that there is no steady-state of the reaction network system. 
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Chapter 8:  Nonlinear dynamics 
Dynamics takes the interactions of objects as the roots of the time behaviors of the 
system. In a chemical reaction network of metabolic signaling pathways, the inter-
actions of metabolites and the other molecules take the forms of variant chemical reac-
tions, especially enzyme catalyzed reactions. Dynamics of the concentration of bioche-
mical species is a systems property that arises through the interaction of metabolites 
and other molecules. 
In general, the nonlinear dynamical behaviors of the insulin signaling network 
depend on control parameters of the chemical reaction network.  By adjusting some of 
the control parameters, we have obtained concentration responses of the network, such 
as the different peak concentrations of membrane GLUT4 in the range of insulin input 
concentration (10-12 M ~ 10-6 M) [17], and oscillations of effector concentrations, 
especially the final product concentration of membrane GLUT4 by ad-justing the 
negative feedback parameters. 
8.1   Effects of insulin input concentration 
Under different input concentrations of insulin, the output responses of membrane 
GLUT4 are also different.  We have examined the concentration of plasma membrane 
GLUT4 under a range of input insulin concentrations (10-12 M ~ 10-6 M).  Our results 
show that for insulin input concentration higher than 10-7 M saturation of the concen-
tration of membrane GLUT4 occurs, while when it is lower than 10-11 M there is non-
response of the concentration of membrane GLUT4 to the insulin regulation.  Figure 28 
shows the dynamic concentrations of membrane GLUT4 in the insulin input concen-
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tration range 10-13 M ~ 10-7 M without insulin removal in Figure 28A and with insulin 
removed at 15 minute in Figure 28B.  The diagrams show that the negative feedback 
induced transient oscillation only exists in higher insulin input concentrations. There is 
a critical insulin input concentration, above which the GLUT4 concentration shows 
transient oscillation, but not below it. Figure 28 shows that this critical insulin concen-
tration is about 3.5 × 10-10 M. 
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A. Concentrations of membrane GLUT4 without removal of insulin 
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B. Concentrations of membrane GLUT4 without removal of insulin 
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Figure ２８:  concentrations of membrane GLUT4 in the step insulin concentration 
range 10-11 M ~ 10-7 M without insulin removal (A) and with insulin removed at 15 
minute (B). 
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In Chapter 3, we have seen the feedback effects on the concentration of the acti-
vated PKC-ζ.  Now we move our focus to the concentration of membrane GLUT4.  
The positive feedback results in an increased concentration of the membrane GLUT4, 
and the negative feedback a decreased one.  When both positive and negative feedbacks 
are switched on, the overall feedback effect is the trade-off between the two feedbacks. 
In Figure 29A the insulin input concentration is relatively higher (insulin = 1.0 × 10-7 
M), the positive feedback increases the concentration of the membrane GLUT4 and the 
negative feedback decreases the same concentration.  Hence, the concentration curve 
with positive feedback lies above the concentration without feedbacks and the concen-
tration curve with the negative feedback below it.  The net feedback is negative except 
for the tail part after the insulin removal, so the concentration curve of membrane 
GLUT4 with both feedbacks lies in between the concentration curves with the positive 
feedback and the negative feed-back.  Most of the curve section in the insulin regula-
tion application time period even lines below the concentration curve without feed-
backs.  But in Figure 29B at a lower insulin in-put concentration (insulin = 3.5 × 10-10 
M) both feedbacks become positive, the positive feedback effect of the negative 
feedback even results in a higher concentration curve than the one with positive feed-
back. The concentration with both feedbacks of course has a net feedback higher than 
the concentration curves with any other feedback conditions.  The removal of insulin 
causes the dropping process of the concentration of the membrane GLUT4 from the 
stimulated high level back to its initial concentration.  In the concentration dropping 
process, we observed the switch of the feedback effect at higher step insulin con-
centration 1.0 × 10-7 M.  That is, the overall feedback effect changes from a negative 
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feedback to a positive one.  Figure 29A shows that the effective feedback-switch of the 
net feedback resulting from the insulin removal.  
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Figure ２９:  Feedback effects on concentration of membrane GLUT4 at different step 
insulin concentrations. (A) At step insulin concentration 1.0 × 10-7 M, the positive 
feedback enhances the concentration of GLUT4 and the negative feedback reduces it. 
The net feedback is a negative one; (B) At step insulin concentration 3.5 × 10-10 M, 
both the negative and negative feedbacks enhances the concentration of membrane 
GLUT4. The net feed-back is a positive one. 
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8.2   Oscillations caused by feedbacks 
It is known in the literature of biochemical networks that negative feedback can cause 
oscillatory behavior and positive feedback can cause instability, such as bistability and 
higher-order bifurcations [ 62 , 63 ].  Theoretical and experimental analyses of the 
present insulin pathways show that only negative feedbacks can cause oscillations in 
chemical reaction networks. By setting up all the feedback conditions such as no 
feedbacks, positive feedback alone, negative feedback alone, and both feedbacks we 
examine the oscillatory behaviors of the effector concentrations.  
The delayed negative feedback has an inhibition effect on the phosphorylation 
reaction of IRS-1 by stimulating the serine-phosphorylation of IRS-1, which is off-path 
from the activation of PI3K.  It reduces the amount of IRS-1 available tyrosine-
phosphorylation and subsequent IRS-1-p/PI3K.  Transient damped oscillatory behavior 
often appears for effectors downstream from IRS-1 at parameter values used by 
Sedaghat, et al. [17].  We have verified that this oscillatory behavior is caused by the 
negative feedback loop.  To understand this nonlinear dynamic behavior, the negative 
feedback parameters, such as the ligand concentration producing half occupation value 
(Kd), and the delay time (τ) are our first choices for the nonlinear dynamical analysis.  
Kd is the dissociation constant of the enzyme-substrate complex, that is, the complex of 
the phosphorylated PKC-ζ and serine-phosphorylated IRS-1. 
The sustained oscillation is realized by varying Kd and τ.  Here below we set τ = 
2 minutes, which is the peaking time of the membrane GLUT4 after the switching-on 
of the insulin full dosage and vary Kd from 5 to 12.  Figure 30 presents a case of sus-
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tained oscillation in the phase space of the concentration of the activated PKC-ζ (x19) 
versus the concentration of the membrane GLUT4 (x21), where Kd = 5.9 and τ = 2 
minute.  
 Just as in the electric circuit, oscillations of the output signals are generally the 
result of deep negative feedbacks [64].  Therefore, by adjusting the strength of the 
negative feedback we can obtain oscillations with changing amplitudes.  According to 
the Hill equation form of the negative feedback expression (3.2), a larger Kd value 
reduces the negative feedback strength [PKC], and results in smaller oscillation 
amplitudes.  Oscillations cannot be sustained for a Kd value greater that about 6 (Figure 
31).  
Oscillations in control systems are usually signs of malfunction, unless we are 
aiming at creating an oscillation.  When a negative feedback control system is unstable 
the actual value of the controlled variable may deviate quite widely from the set value 
[65].    
 
 
  110
33.5
4
4.5
5
5.5
6
23.8 24.3 24.8 25.3 25.8 26.3 26.8
Concentration of x21 (%) 
C
on
ce
nt
ra
tio
n 
of
 x
19
 (%
)
Vmax=20, Kd=5.9, Tau=2 min
 
Figure ３０:  Phase diagram of the concentration of the activated PKC-ζ (x19) versus 
the concentration of membrane GLUT4 (x21) when the negative feedback parameters 
are adjusted to result in concentration oscillations. Here the parameter values are Kd = 
5.9 and τ = 2 minute. 
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Figure ３１:  Increasing of Kd value results in weaker negative feedback signals results 
in damped oscillation amplitudes but increase values of the concentration of membrane 
GLUT4.   
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8.3   Damping effects from phosphatases 
In the PIP module, there are two phosphatases SHIP and PTEN, which dephosphorylate 
PI(3,4,5)P3, which is the kinase of the PKC and Akt phosphorylation in the downstream 
subsequent PKC/Akt module. More specifically, SHIP dephosphorylates PI(3,4,5)P3 to 
PI(3,4)P2 and PTEN dephosphorylates PI(3,4,5)P3 to PI(4,5)P2. Figure 32 shows that a 
higher SHIP concentration not only reduces the concentration, but also damps the oscil-
lation amplitude of the membrane GLUT4.  In the present models the dephosphoryla-
tion effect of SHIP and PTEN are both expressed in the form of a multiplier to the nor-
mal dephosphorylation rate k-10 of k-9, and k-9 has a larger value than that of k-10.  There-
fore, the inhibition of PTEN is more effective than that of SHIP. Our result confirms 
this prediction.  
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Figure ３２:  Damping effect of phosphatase SHIP on the oscillation amplitudes and 
concentration value.  A higher concentration reduces the production of membrane 
GLUT4 and damps the oscillation amplitude of membrane GLUT4. 
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8.4   Power spectra 
Power spectrum analysis is the application of Fourier transform to the sampling data.  It 
reveals the frequency distribution of an oscillation.  The nonlinear terms in the rate 
equation are composed of the productions of more than one concentration of reaction 
species, resulting in the coupling effects of the reaction network.  The strength of the 
coupling is reflected by the spectra intensities of the overtones of the oscillations.  
Power spectra show that there are frequencies embedded in a time series, here 
the concentration dynamics associated with the insulin signaling pathways.  In Figure 
33A, we see that a fundamental frequency and the overtones are observed in the power 
spectrum of the unphosphorylated IRS-1 (x9).  The fundamental frequency is 1.375 Hz 
and the first, second, third, and fourth overtones are 2.751 Hz, 4.131 Hz, 5.502 Hz, and 
6.873 Hz, respectively.  The readings have some errors because of the fine structures of 
the power spectrum.  In Figure 33B, we enlarged the scale of the fundamental 
frequency, the fine structure shows that the spectrum line actually splits into two close 
spectrum lines with the frequency separation about 8.79 × 10-3 Hz.  In the Figure 33A, 
we can see that some over-tone peaks are asymmetric in shape. 
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A. Power spectrum of the unphosphorylated IRS-1 
0
2
4
6
8
10
12
14
16
0 2 4 6 8 10 12 14 16 1
Frequency (Hz)
Po
w
er
 In
te
ns
ity
 (a
rb
. u
ni
t)
8
Kd=5
 
B. Enlargement of the fundamental frequency peak  
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Figure ３３:  Power spectrum of the unphosphorylated IRS-1 in (A), showing the 
fundamental frequency and the overtones. (B) is the zoomed-in diagram of the 
fundamental frequency to highlight the fine-structure. 
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As the value of Kd increases, the intensities of the overtones are reduced, 
implying that the oscillation becomes more monochromosome. We can also see the 
increased intensity of the low frequency noise background (Figure 34).  The same dia-
gram shows that the fundamental frequency and correspondent overtone values have a 
‘red shift’ as the control parameter Kd increases.  Also at higher Kd, the peak intensities 
of the fundamental frequency and overtones are reduced, reflecting the reduced 
oscillation amplitudes we have seen in subsection 8.2.  The Kd effect on the power 
spectra may reveal the changing of the imaginary parts of the eigenvalues associated 
with the limit cycles, if they exist in the current system.  
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A. Power spectra of the activated PKC-ζ (x19) with different Kd values 
30
32
34
36
38
40
42
0 1 2 3 4 5 6 7 8 9
Frequency (Hz)
Po
w
er
 In
te
ns
ity
 (a
rb
. u
ni
t)
Kd=5.0
Kd=5.5
Kd=5.9
 
B. Enlargement of the fundamental frequency in (A) 
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Figure ３４:  The power spectra of the activated PKC-ζ at various Kd values. As Kd 
increases, the fundamental frequency is reduced but the fine-structures remain.  (A) 
The overall power spectrum, B) Enlargement of the fundamental frequency peaks. 
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Chapter 9:  Delivery profile of insulin 
Because membrane GLUT4 is responsible for glucose uptake by the tissue cells and 
relief of the symptom of diabetes, we set as one of our goals to delay and reduce the 
backflow of GLUT4 exocytosis, that is, a flux from membrane form of GLUT4 to 
intracellular form.  The control study in Chapter 6 shows that for a fixed total amount 
of insulin, a continuous curve delivery, such as Gaussian curve delivery of insulin, can 
significantly improve the concentration distribution of membrane GLUT4 compared to 
that of the step function de-livery considered in Sedaghat, et al. [17]. This motivates us 
to investigate the effects of changing the insulin delivery profiles, that is, changing the 
functional form of the delivery curve.  
9.1  Continuous insulin delivery 
We have considered several functional forms of delivery: Step function distribution, 
Gaussian distribution, exponential distribution, and Rayleigh distribution.  In all the re-
sults presented below, the insulin dosage D is kept at the constant value of 
D = 10-7 M × 15 min. 
The step function is the simplest form of delivery.  We change the step-width w 
and the concentration is calculated by D/w. The expression for insulin delivery is 
([ wt
w
Dx −−= θ11 )],        (9.1) 
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where θ(s) is the Heaviside function.  θ (s) = 1 for s ≥ 0, 0 otherwise.  The step insulin 
delivery curves are shown in Figure 35A for several step-widths, the resulting concen-
tration curves of membrane GLUT4 are presented in Figure 36A. 
 The Gaussian distribution is  
( )
2
2
0
2
2
1 σ
πσ
ss
ey
−−= ,        (9.2) 
where σ is the standard deviation, s is the independent variable and s0 is the mean of s.  
The coefficient πσ 2
1  is the normalization factor for the period (- ∞, + ∞).   
In our research, we set the mean time t0 = 0, t takes positive time (0, + ∞).  
Since the Gaussian curve is symmetrical with respect to the mean time, the integration 
over the positive time period only.  The normalized half-Gaussian curve for insulin 
delivery then becomes 
2
2
2
1 2
2 σ
πσ
t
eDx
−= .        (9.3) 
where D is the constant cumulative insulin dosage.  By adjusting the standard deviation 
σ we obtain different insulin delivery curves for a fixed cumulative insulin dosage D.  
The Gaussian insulin delivery curves are shown in Figure 35B for several σ’s, the 
resulting concentration curves of membrane GLUT4 are presented in Figure 36B. 
The exponential form of insulin delivery is given by, 
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00
1
t
t
e
t
Dx
−= ,          (9.4) 
where t0 is the life-time.  The coefficient 
0t
D  is the normalization factor.  By adjusting 
the life-time t0 we vary the peak value of the insulin concentration, thus the delivery 
curve.  The exponential insulin delivery curves are shown in Figure 35C for several t0’s, 
the resulting concentration curves of membrane GLUT4 are presented in Figure 36C. 
 The Rayleigh expression of the insulin delivery is 
 2
2
21
σ
σ
t
teDx
−= ,        (9.5) 
where σ is the standard deviation.  The coefficient 2σ
D  is the normalization factor.  
Again the peak concentration of insulin can be varied by adjusting the standard de-
viation.  The Rayleigh insulin delivery curves are shown in Figure 35Dfor several σ’s, 
the resulting concentration curves of membrane GLUT4 are presented in Figure 36D. 
To summarize and compare results, we present in Table 9 the integrated con-
centrations of membrane GLUT4 stimulated by different insulin deliveries.  In step-
function, Gaussian, exponential, and Rayleigh deliveries, we set the values of the step-
width, standard deviation, life-time, and standard deviation to be the same series – 10 
minute, 20 minute, 30 minute, 40 minute, and 50 minute.  For each delivery, a larger 
adjustable value results in a larger cumulative concentration of membrane GLUT4 for a 
fixed amount of insulin delivered.  The three continuous deliveries, Gaussian, expo-
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nential, and Rayleigh deliveries, result in improved cumulative concentrations of mem-
brane GLUT4.  From the table we can see the exponential delivery has the best output 
performance for each adjusted parameter value. 
From the control analysis of Chapter 6, we learn that the optimal distribution of 
membrane GLUT4 is obtained by maintaining its maximal concentration (~ 35%) for 
as long a duration as possible. Therefore, for a fixed integrated insulin dosage, we can 
increase the insulin delivery time, thus reduce the maximal insulin concentration to 
maintain the high concentration of membrane GLUT4 for as long as possible.  In the 
case of step-function delivery, the height of the step dosage function can be lowered to 
increase the duration of insulin input.  On the other hand, as will be shown in the next 
subsection 9.2, continuous insulin delivery functions like Gaussian can reduce the 
backflow caused by the sudden removal of insulin and improve curve shape of concen-
tration.  This is because continuous delivery profiles have smoothly continuous 
damping tails than that of step insulin function, which will reduce the backflow caused 
by the sudden removal of insulin.   
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Figure ３５:  Concentration curves of the four insulin delivery functions and the with 
adjusted parameter values to improve the output of the reaction network with fixed 
insulin dosage. (A) is the step distribution function, step width is adjusted; (B) is 
Gaussian distribution function, standard deviation is adjusted; (C) is the exponential 
distribution function, life time is adjusted; (D) is the Rayleigh distribution function, 
standard deviation is adjusted.  
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Figure ３６:  The concentration curves of membrane GLUT4 under different insulin 
de-livery curves with altered parameters to improve the delivery output.  (A) is the 
result from step distribution functions, (B) is from the Gaussian distribution functions, 
(C) is from exponential distribution functions, (D) is from Rayleigh distribution 
functions. 
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Table 9:  Integrated concentrations of membrane GLUT4 with different insulin delivery 
functions and adjusted parameter values. 
Integrated concentration at different parameter values 
(%⋅min) Delivery function 
Parameter 
adjusted 10 (min) 20 (min) 30 (min) 40 (min) 50 (min) 
Step-function Step-width 858.84 1161.11 1462.48 1762.99 2062.61 
Gaussian STD 1411.29 2296.52 3174.60 4033.09 4871.42 
Exponential Life-time 2270.14 3888.78 5375.19 6770.66 8088.50 
Rayleigh STD 1181.52 1830.09 2483.88 3129.86 3761.73 
 
 
9.2 Reduction of backflow under continuous insulin delivery 
In the non-equilibrium thermodynamic analysis we have seen that for step-function 
delivery the cumulative backflow remains almost constant independent of the removal 
time of insulin.  This is not the case in the continuous curve delivery.  Since the insulin 
concentration is gradually reduced, the regulation effect on the GLUT4 exocytosis is 
also significantly improved.   
Figures 37, 38, and 39 show, respectively, the fluxes, chemical affinities, and 
entropy production rates for different insulin deliveries.  In each of the three figures, 
there are four diagrams A, B, C, and D which correspond to the cases of step-function, 
Gaussian, exponential, and Rayleigh function deliveries in order.  From these figures 
(Figures 37 – 39) we can see that continuous insulin delivery functions of Gaussian, 
exponential, and Rayleigh deliveries result in reduced backflows, chemical affinities, 
and entropy production rates compared to those of the step-function deliveries.   
In Table 10, we present the integrated EPR, which is actually the total entropy 
production over the integration time period, associated with the backflows for the step-
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function, Gaussian, exponential, and Rayleigh insulin deliveries with their respective 
adjustable variable values, the same formats as those presented in Figures 35, 36 and 
Table 9.  Clearly shows that, in step-function deliveries, a larger step width does not 
reduce the entropy production, but slightly increases it.  In the three continuous 
deliveries, on the other hand, the entropy production rates decrease with the adjustable 
variable parameters, that is, a larger adjustable parameter results in less entropy 
production. In particular, exponential deliveries seem to bring about the most 
reductions of the entropy production.   
 
 
 
 
 
 
 
 
 
 
  127
A. Fluxes of GLUT4 exocytosis under step insulin deliveries 
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B. Fluxes of GLUT4 exocytosis under Gaussian insulin deliveries 
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C. Fluxes of GLUT4 exocytosis under exponential insulin deliveries 
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D. Fluxes of GLUT4 exocytosis under Rayleigh insulin deliveries 
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Figure ３７ :  The fluxes of GLUT4 translocation process under different insulin 
delivery curves with altered parameters to improve the delivery output.  (A) is the 
result from step function distributions, (B) is from the Gaussian distribution functions, 
(C) is from exponential distribution functions, (D) is from Rayleigh distribution 
functions. 
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A. Chemical affinities of GLUT4 exocytosis under step insulin deliveries 
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B. Chemical affinities of GLUT4 exocytosis under Gaussian insulin deliveries 
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C. Chemical affinities of GLUT4 exocytosis under exponential insulin deliveries 
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D. Chemical affinities of GLUT4 exocytosis under Rayleigh insulin deliveries 
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Figure ３８:  The chemical affinities of GLUT4 translocation process under different 
insulin delivery curves with altered parameters to improve the delivery output.  (A) is 
the result from step function distributions, (B) is from the Gaussian distribution 
functions, (C) is from exponential distribution functions, (D) is from Rayleigh 
distribution functions. 
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A.  EPRs of GLUT4 exocytosis under step insulin deliveries 
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B.  EPRs of GLUT4 exocytosis under Gaussian insulin deliveries 
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C.  EPRs of GLUT4 exocytosis under exponential insulin deliveries 
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D.  EPRs of GLUT4 exocytosis under Rayleigh insulin deliveries 
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Figure ３９:  The Entropy production rates (EPRs) of GLUT4 translocation process 
under different insulin delivery curves with altered parameters to improve the delivery 
output.  (A) is the result from step function distributions, (B) is from the Gaussian 
distribution functions, (C) is from exponential distribution functions, (D) is from 
Rayleigh distribution functions. 
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Table 10:  The entropy production of backflows in GLUT4 translocation processes 
under different insulin deliveries. 
Entropy production at different parameter values 
(%⋅min) Delivery function 
Parameter 
adjusted 10 (min) 20 (min) 30 (min) 40 (min) 50 (min) 
Step-function Step-width 10.03470 10.32902 10.35972 10.37085 10.38053 
Gaussian STD 9.71076 7.66882 5.68989 4.37200 3.50761 
Exponential Life-time 5.09013 2.67588 1.80531 1.36216 1.09324 
Rayleigh STD 9.99651 8.95337 7.34848 5.93582 4.88248 
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Chapter 10:  Summary 
We have conducted the in silico time-dependent sensitivity analysis, non-equilibrium 
thermodynamic analysis, and nonlinear dynamic analysis, and input profile control 
strategies study of the mathematical models of metabolic insulin signaling pathways 
developed by Sedaghat, et al. [17].  We have also applied control strategies and studied 
effect of varying the insulin delivery function form to the same models.  Our results to 
date have unraveled many features of the models, made biochemically meaningful 
predictions, and provided operable ideas on the treatment of diabetes.    
The present sensitivity analysis can be considered as an extension of the more 
traditional metabolic control analysis (MCA), which has a long history [49-53].  The 
main extensions or differences are that the focus here is on the signaling pathways, 
time-dependent sensitivities, and their implications on systems dynamics, and the use 
of integrated sensitivities in, for example, in the ranking of drug targets.  The 
advantages of using MCA for drug target and drug discovery in metabolic systems 
have been already pointed out several years ago in the literature [66].  This present 
analysis shares many of the same advantages of the analysis discussed there.  
The dynamic sensitivity analysis results reveal shape similarity of some 
sensitivity curves, determined by the reaction kinetics of the models. We have also 
ranked the vulnerability points of the pathways according to the integrated sensitivities 
of membrane GLUT4 with respect to the parameters of the system, namely reaction 
rate parameters as well as non-zero initial concentrations of system effectors.  The 
ranking lists serve as guidelines to potential drug targets in the insulin pathways.  
  135
Furthermore, two control strategies have been applied to the system; one aims at a tar-
get concentration at a specific time-point, another aims at an objective time-integrated 
output in a specific interval.   The control strategies reveal that the continuous smooth 
delivery of the insulin for diabetic patients should result in improved membrane 
GLUT4 concentration profile. We hope that the results shed light on the systems 
behaviors of the insulin pathways, have the potential of bringing out novel drug targets, 
and have implications in improving treatments of diabetes patients. 
A signaling pathway is a system far from equilibrium and for the present insulin 
model systems away from steady states, which has been seen in Chapter 7.  Therefore 
equilibrium thermodynamics is not applicable for the analysis of the systems behavior; 
instead we should use non-equilibrium thermodynamics.  Applications of non-equili-
brium thermodynamics to the analysis of insulin pathways reveal the dynamic beha-
viors of fluxes, chemical affinities, and entropy production rates of the reactions in the 
network.  Flux analysis clearly show backflows induced by the removal of insulin un-
der different feedback conditions.  In our control and delivery profile studies we try to 
delay or reduce backflows to improve the concentration distribution of membrane 
GLUT4.  The chemical affinity and entropy production rate studies provide comple-
mentary views by revealing the dynamic driving force of the reactions and the dissi-
pated energy production of the reactions.   
The dynamic analysis of the reaction network reveals the oscillations driven by 
the negative feedback. By adjusting the parameters of the negative feedback loop, we 
obtain sustained oscillations.  The fundamental frequency and overtone structure of 
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power spectra of oscillatory concentrations reveals the signal strength of the negative 
feedback, and the nonlinearly of the network.  The amplitudes and frequencies are 
affected by the delay and the dissipation rate in the Hill equation (3.2).  Phosphatases, 
as expected, have inhibitory effects on oscillations.   
With the medical intervention in mind we try to control the backflow by 
varying the insulin delivery curve. By using continuous curve delivery we obtain 
significant improvements in the elongated duration of high concentration of membrane 
GLUT4 over and above, that of the step-function delivery considered by Sedaghat, et al. 
[17].  This provides a way to optimize the treatment effect with limited insulin dosage.  
We hope that this up-to-date result can contribute to the improvement of treatments.   
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Chapter 11:  Discussion and future directions 
The well known fact is that the negative feedback triggers the oscillations and positive 
feedbacks cause bifurcations in the chemical reaction network [62,63,67].   The present 
models contain both a positive feedback loop and a negative feedback loop, which 
provide enriched opportunities for the study of oscillation, bifurcation and instability.  
A careful nonlinear dynamics study of the system is yet to be carried out.  By switching 
off the synthesis and degradation rates mentioned above, we can then find the steady 
states of the system as a function of control parameters.  linear stability analysis about 
these steady states will give us information on bifurcations and bistability of the system.  
In particular, we anticipate the existence of limit cycles via Hopf bifurcations as-
sociated with the oscillatory behavior studied in the thesis.  On the other hand, Giri, et 
al. [20] discussed the presence of bistable behavior of an insulin model derived from 
the Sedaghat models.  Furthermore, together with the expected improvement of the 
phenomenological expressions of the reaction rates, more interesting dynamic 
behaviors of the network can be expected.  
The predictions and rankings of drug targets, the applicability of variant insulin 
delivery profiles carried out in our research, of course, depend on the models of the 
pathway network used.  Because of the constant improvements in our understanding of 
the molecular mechanisms of the protein-protein interactions, feedback loops involved, 
and cross-talks between pathways, the models can only be improved and extended.  
Because of the phenomenological nature of the Sedaghat models, there is room for 
improvements.  However, each extension involves the refitting of all reactions rates and 
parameters to experimental data available.  On the other hand, an improved model 
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allows better predictions of drug targets and allows closer comparison with the 
experimental developments in drug targets.  Some of the obvious improvements of the 
models could be: writing down the enzymatic reactions for the kinases or phosphatases 
involved, or at least, expressing the reactions in terms of Michaelis-Menton formulas 
[68,69].   Phosphatases, such as PTP, can be treated explicitly as chemical species in 
the model.  The fact that PTP dephosporylates activated IRS-1, activated insulin 
receptors, and internalized activated insulin receptors act as cross-talks of the model, if 
PTP is treated explicitly as a dynamic variable.    
The metabolic rates related to protein syntheses and degradations, k5, k-5, k14, 
and k-14, do not play important roles on the sensitivities of the membrane GLUT4.  The 
existence of these rates makes the network an open system.  One consequence of this 
fact is that the total concentration of the intracellular GLUT4 and membrane GLUT4 
can be, and in practice is slightly, greater than unity.  In order to study the nonlinear 
dynamic behaviors (steady states and limit cycles) of the system, one may have to 
switch off the synthesis and degradation rates of unbound intracellular insulin receptors 
and intracellular GLUT4s.  
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